triazoles has been researched along with Mycoses in 903 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (3.99) | 18.7374 |
| 1990's | 33 (3.65) | 18.2507 |
| 2000's | 346 (38.32) | 29.6817 |
| 2010's | 453 (50.17) | 24.3611 |
| 2020's | 35 (3.88) | 2.80 |
| Authors | Studies |
|---|---|
| Boechat, N; Castelo-Branco, FS; França, RRF; Hoelz, LVB; Menozzi, CAC | 1 |
| Panagopoulou, P; Roilides, E | 1 |
| Fang, JP; Wang, J; Zhang, YT; Zhou, DH | 1 |
| Berastegui, C; Bravo, C; Campany-Herrero, D; Castells, L; Deu, M; Gavaldà, J; Len, O; Los-Arcos, I; Márquez-Algaba, E; Martín-Gómez, MT; Monforte, A; Moreso, F; Nuvials, X; Sacanell, J; Sempere, A | 1 |
| Ben-Ami, R; Brüggemann, RJ; Busca, A; Cornely, OA; de Jonge, N; Lewis, R; Piechotta, V; Ráčil, Z; Sinkó, J; Skoetz, N; Stemler, J | 1 |
| Dong, R; Fang, Y; Jin, W; Lin, N; Shan, Q; Shi, C; Wang, L; Xie, Y; Ye, J | 1 |
| Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y | 1 |
| de Almeida, C; de Greef, R; Fauchet, F; Hasegawa, C; Iwasa, T; Winchell, GA; Wrishko, RE; Yoshitsugu, H | 1 |
| Barbi, A; Croubels, S; De Baere, S; De Troyer, N; Deknock, A; Goessens, T; Goethals, P; Greener, M; Lens, L; Martel, A; Pasmans, F; Strubbe, D; Van Leeuwenberg, R; Verbrugghe, E | 1 |
| Kozaki, T; Mizuhata, J; Ose, A; Shirae, S; Tsuruya, Y | 1 |
| Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP | 1 |
| Albert, ND; Beyda, ND; Kontoyiannis, DP; Lewis, RE; Wurster, S | 1 |
| Cardozo, C; Chumbita, M; García-Vidal, C; Moreno-García, E; Puerta-Alcalde, P | 1 |
| Ahlmann, M; Fröhlich, B; Gastine, S; Groll, AH; Herbrüggen, H; Müller, C; Thorer, H; Tragiannidis, A; Vasileiou, E | 1 |
| Li, R; Sun, L; Wan, Z; Yu, J | 1 |
| Atanasova, L; Bogáts, G; Büchner, R; Cai, F; Chenthamara, K; Dóczi, I; Druzhinina, IS; Hatvani, L; Homa, M; Kocsubé, S; Kredics, L; Manikandan, P; Mlinaric-Missoni, E; Narendran, V; Revathi, R; Vágvölgyi, C | 1 |
| Bowolaksono, A; Chen, X; Indriani, CI; Kajiwara, S; Niimi, K; Niimi, M; Utami, ST; Yaguchi, T | 1 |
| Bivins, CA; Borthakur, G; Bose, P; Daver, N; Estrov, Z; Huang, X; Kadia, TM; Kantarjian, HM; Konopleva, M; Kontoyiannis, DP; Marx, KR; Masarova, L; McCue, D; Naqvi, K; Pemmaraju, N; Pierce, SA; Qiao, W; Rausch, CR; Ravandi, F; Takahashi, K; Wiederhold, NP; Wurster, S; Yilmaz, M | 1 |
| Baretta, V; Calore, E; Carraro, F; Cesaro, S; Colombini, A; D'Amico, MR; Mauro, M; Muggeo, P; Perruccio, K; Tridello, G; Zama, D | 1 |
| Candoni, A; Facchin, G; Fanin, R; Lazzarotto, D | 1 |
| Balfour-Lynn, IM; Bentley, S; Carr, SB; Davies, JC | 1 |
| Borman, AM; Fraser, M; Hughes, JM; Johnson, EM; Noel, AR; Oliver, D; Sunderland, J | 1 |
| Grigg, A; Hughes, CFM; Robinson, DH | 1 |
| Gómez-López, A | 1 |
| Álvarez Duarte, E; Salas, V | 1 |
| Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR | 1 |
| Diana, A; Isabel Cristina, RS; Karen, A | 1 |
| Abdul-Hamil, NA; Cherchione, C; Martinelli, G; Nagarajan, C; Wong, GC | 1 |
| Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF | 1 |
| Armstrong-James, D; Pagani, N; Reed, A | 1 |
| Alexander, S; Chen, L; Dang, H; Dvorak, CC; Esbenshade, AJ; Fisher, BT; Nieder, ML; Skeens, M; Steinbach, WJ; Sung, L; Villaluna, D; Zaoutis, TE | 1 |
| Kong, WF; Lang, Q; Pasheed Chughtai, A; Yan, HY | 1 |
| Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP | 1 |
| Arikan, K; Aytac, S; Büyükcam, A; Cengiz, AB; Cetin, M; Cetinkaya, FD; Ceyhan, M; Kara, A; Ozsurekci, Y | 1 |
| Del Principe, MI; Marchesi, F; Menna, P; Minotti, G; Pagano, L; Perrone, S; Salvatorelli, E | 1 |
| Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM | 1 |
| Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW | 1 |
| Aleissa, MM; Alshehri, BS; Gonzalez-Bocco, IH; Leblebjian, H; Luskin, MR; Marty, FM; McDonnell, AM | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, P | 1 |
| Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Birch, M; Law, D; Wiederhold, NP | 1 |
| Cornely, OA | 1 |
| Ai, H; Chen, J; Han, M; Hu, J; Huang, H; Huang, X; Ji, Y; Liang, Y; Ma, J; Meng, F; Tang, Y; Wu, D; Zhang, R; Zhang, X | 1 |
| Berking, S; Doedens, D; Fiegl, M; Horns, H; Ostermann, H; Rieger, CT | 1 |
| Aversa, F; Busca, A; Candoni, A; Cattaneo, C; Cesaro, S; De Luca, A; Delia, M; Dragonetti, G; Fanci, R; Guglielmi, G; Lessi, F; Martino, G; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Tumbarello, M; Verga, L | 1 |
| Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J | 1 |
| Dong, WH; Dong, YL; Li, JX; Wang, TT; Wang, Y; Zhang, GZ | 1 |
| Cao, YB; Gao, YH; Li, SW; Li, XH; Wang, HT; Wang, L; Wu, XX; Wu, YM; Xu, LX; Yan, B; Zhang, TT; Zhang, YQ | 1 |
| Gong, BF; Gong, XY; Gu, RX; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Qiu, SW; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL | 1 |
| Ho, CL; Lee, CH; Lin, C; Lin, JC; Sun, M; Yen, WT | 1 |
| Ahmadi, B; Alshahni, MM; Ansari, S; Badali, H; Makimura, K; Mirhendi, H; Rezaei-Matehkolaei, A; Shokoohi, GR; Vaezi, A | 1 |
| Chen, L; Dong, W; Dong, Y; Li, Y; Meng, T; Wang, Y; Xie, J; Xing, Y | 1 |
| Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT | 1 |
| Cases Viedma, E; García-Robles, AA; Jordá, C; Mancheño, N; Pemán, J; Poveda-Andrés, JL; Reig Mezquida, JP; Solé, A | 1 |
| Bernier, B; Bondue, B; Etienne, I; Jacob, F; Knoop, C; Lecomte, S; Montesinos, I; Taton, O | 1 |
| Patterson, TF; Thompson, GR | 1 |
| Ertem, M; İleri, T; İnce, E; Pekpak, E; Uysal, Z | 1 |
| Berger, M; Calore, E; Carraro, F; Cesaro, S; Decembrino, N; Molinaro, M; Perruccio, K; Putti, MC; Rossin, S; Tridello, G; Vicenzi, EB | 1 |
| Chen, C; Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Heep, M; Lademacher, C; Maher, R; Marty, FM; Mullane, KM; Ostrosky-Zeichner, L; Perfect, JR | 1 |
| Chen, L; Dong, Y; Hao, R; Li, Y; Liu, L; Meng, T; Wang, Y; Zhang, T | 1 |
| Castanheira, M; Pfaller, MA; Rhomberg, PR | 1 |
| Berman, E; Epstein, DJ; Frattini, MG; Huang, YT; Klimek, VM; Papanicolaou, GA; Park, JH; Seo, SK; Tallman, MS | 1 |
| Costanzo, CM; Oliveri, S; Palermo, CI; Scalia, G; Trovato, L | 1 |
| Martínez-Matías, N; Rodríguez-Medina, JR | 1 |
| Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR | 1 |
| DiPippo, AJ; Kontoyiannis, DP; Rausch, CR | 1 |
| Downes, KJ; Ellis, D; Fisher, BT; Lavigne, S; Zaoutis, TE | 1 |
| Marini, BL; Perissinotti, AJ | 1 |
| Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM | 1 |
| Asbury, KL; Delafield, NL; Kenny, G; Lambert, KL; Larsen, BT; Moran, C; Patron, RL | 1 |
| Bakker, M; C Alffenaar, JW; Märtson, AG; Span, LFR; Touw, DJ; van den Heuvel, ER; van der Werf, TS; Veringa, A | 1 |
| Athans, V; Brizendine, KD; Hassouna, H | 1 |
| Cardozo, C; Diago, E; Enzenhofer, M; Fortun, J; Frutos, A; Garcia-Vidal, C; Gioia, F; Gudiol, C; José Castón, J; López, J; Machado, M; Martín-Dávila, P; Muñoz, P; Parody, R; Puerta-Alcalde, P; Ramos, A | 1 |
| Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M | 1 |
| Emami, S; Ghobadi, E; Hashemi, SM; Saednia, S | 1 |
| Kontoyiannis, DP; Li, R; Liu, W; Shi, X; Tan, J; Wan, Z; Zhang, H; Zhou, Y; Zhu, P | 1 |
| Paiva, JA; Pereira, JM | 1 |
| McLaren, A; McLemore, R; Pauken, C; Schmidt, K | 1 |
| Athanasakis, K; Kyriopoulos, J; Petrakis, I | 1 |
| Gao, Y; Ping, B; Wu, B; Yue, C; Zhu, Y | 1 |
| Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC | 1 |
| Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K | 1 |
| Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK | 1 |
| Charles, JI; Jeanbourquin, D; Mostofi, K | 1 |
| Bulacio, L; Escovich, L; López, C; Pairoba, C; Paz, M; Ramadán, S; Ramos, L; Sortino, M | 1 |
| Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K | 1 |
| Itälä-Remes, M; Remes, K; Salmenniemi, U | 1 |
| Berry, A; Cardeau-Desangles, I; Cassaing, S; Cointault, O; Esposito, L; Fabre, A; Guitard, J; Iriart, X; Kamar, N; Valentin, A | 1 |
| Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS; Uras, N | 1 |
| Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z | 1 |
| Huenecke, S; Klingebiel, T; Koehl, U; Latgé, JP; Lehrnbecher, T; Roeger, F; Schmidt, S; Schubert, R; Tramsen, L | 1 |
| Blennow, O; Kalin, M | 1 |
| Dolton, MJ; McLachlan, AJ | 2 |
| Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, L; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Zegans, ME | 1 |
| Ostermann, H; Ostermann, J; Peterson, L; Rieger, CT; Rieger, H | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Woosley, LN | 1 |
| Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M | 1 |
| Goto, T; Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, J; Kawasaki, K; Sato, Y; Suzuki, Y; Tokimatsu, I | 1 |
| Cornely, OA; Glossmann, J; Hallek, M; Heimann, SM; Kochanek, M; Kreuzer, KA; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Byrnes, E; Datta, K; Garcia-Effron, G; Marr, KA; Perlin, DS; Rhee, P; Staab, JF | 1 |
| Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M | 1 |
| Heng, SC; Keating, D; Kong, DC; Levvey, B; Morrissey, O; Nation, RL; Slavin, MA; Snell, GI; Westall, GP; Whitford, H; Williams, TJ | 1 |
| Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X | 1 |
| Engelhardt, M; Gross, BN; Ihorst, G; Jung, M; Wäsch, R | 1 |
| Einsele, H; Grau, A; Heinz, WJ; Helle-Beyersdorf, A; Klinker, H; Lenker, U; Schirmer, D; Zirkel, J | 1 |
| Alffenaar, JW; Greijdanus, B; Kosterink, JG; Span, LF; Uges, DR; van der Elst, KC; van der Werf, TS; van Hateren, K; Vermeulen, KM | 1 |
| Campoli, P; Filler, SG; Kristof, AS; Perlin, DS; Sheppard, DC; White, TC | 1 |
| Cho, BS; Choi, JH; Choi, SM; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Lee, S; Min, CK; Min, WS; Park, SH; Yoo, JH | 1 |
| Chen, FP; Chen, XQ; Hu, JD; Huang, XJ; Jin, J; Li, Y; Liang, YM; Liu, T; Shen, Y; Shen, ZX; Wang, JX; Wang, SJ; Wu, DP; Yu, K; Yu, L | 1 |
| Baden, LR; Bolaños-Meade, J; Brown, JM; Chirila, C; Gersten, ID; Graham, J; Horowitz, MH; Kurtzberg, J; Leather, H; Marr, KA; Mauskopf, J; Maziarz, RT; Walsh, TJ; Wingard, JR | 1 |
| Bertz, H; Drognitz, K; Lübbert, M | 1 |
| Calzada, JI; Diaz, RI; Randolph, JC; Sigler, EJ | 1 |
| Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B | 1 |
| Böhme, A; Buchheidt, D; Cornely, OA; Egerer, G; Heinz, W; Krüger, W; Link, H; Maschmeyer, G; Mousset, S; Neumann, S; Ostermann, H; Panse, J; Penack, O; Rieger, C; Ruhnke, M; Schmidt-Hieber, M; Silling, G; Südhoff, T; Ullmann, AJ; Wolf, HH | 1 |
| Boongird, A; Chongtrakool, P; Jirasiritham, S; Larbcharoensub, N; Sumethkul, V; Watcharananan, SP; Wirojtananugoon, C | 1 |
| Candoni, A; Cojutti, P; Fanin, R; Franceschi, L; Pea, F; Simeone, E | 1 |
| Allione, B; Audisio, E; Aydin, S; Barbui, AM; Busca, A; D'Ardia, S; De Rosa, FG; Dellacasa, CM; Falda, M; Frairia, C; Manetta, S; Marmont, F; Pecoraro, C; Vitolo, U | 1 |
| Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA | 1 |
| Leroux, S; Ullmann, AJ | 1 |
| Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF | 1 |
| Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H | 1 |
| Goletz, G; Groll, AH; Jürgens, H; Kolve, H; Pieper, S; Yunus, S | 1 |
| Park, SW; Patel, RV | 1 |
| Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE | 1 |
| Al-Badriyeh, D; Dinleyici, EC; Kara, A; Kong, DC; Senol, E; Turner, SJ | 1 |
| Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O | 1 |
| Geng, RX; Peng, XM; Rasheed, S; Yan, CY; Yin, BT; Zhang, SL; Zhou, CH | 1 |
| Caira, M; Pagano, L | 1 |
| Chan, RC; Larsen, SR; van Hal, SJ | 1 |
| Kim, DY; Lee, YJ; Park, HJ | 1 |
| Ascioglu, S; Chan, KA | 1 |
| Acharya, NR; Cevallos, V; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Sun, CQ | 1 |
| Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK | 1 |
| Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Drew, RH; Johnson, MD; Kung, HC; Perfect, JR; Saha-Chaudhuri, P | 1 |
| Campoli, P; Duarte, RF; Sheppard, DC | 1 |
| Caceres, M; Cornely, OA; Heinz, WJ; Kartsonis, N; Krishna, G; Maertens, J; Patino, H; Robertson, MN; Ullmann, AJ; Waskin, H | 1 |
| Bangard, C; Cornely, OA; Shimabukuro-Vornhagen, A; Tran, L; Vehreschild, JJ; Vehreschild, MJ; von Bergwelt-Baildon, M; Wisplinghoff, H | 1 |
| Li, BJ; Liu, XH; Shi, YX; Sun, GX; Sun, ZH; Wu, HK; Yang, MY; Zhang, YG | 1 |
| Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J | 1 |
| Duarte, M; Foppa, M; Goldani, L; Jeffman, M; Rohde, LE; Sprinz, E; Torres, FS | 1 |
| Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B | 1 |
| Arnoldner, MA; Durand, ML; Hamrah, P; Jakobiec, FA; Kheirkhah, A | 1 |
| Azoulay, E; Bergeron, A; Bretagne, S; Lafaurie, M; Lerolle, N; Molina, JM; Porcher, R; Raffoux, E; Sauvageon, H; Socie, G; Touratier, S | 1 |
| Blennow, O; El-Serafi, I; Eliasson, E; Hassan, M; Mattsson, J; Pettersson, T; Pohanka, A; Ringdén, O; Szakos, A | 1 |
| Fung, HC; Peksa, GD; Schultz, K | 1 |
| Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA | 1 |
| Aversa, F; Ballanti, S; Busca, A; Caira, M; Candoni, A; Castagnola, C; Cattaneo, C; Fanci, R; Lessi, F; Martino, B; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Salutari, P; Tumbarello, M; Verga, L | 1 |
| Choudhury, S; Marte, RL | 1 |
| Fernández-Silva, F; Guarro, J; Lackner, M; Lass-Flörl, C | 1 |
| Bourdelin, M; Daguindau, E; Deconinck, E; Desbrosses, Y; Dubut, J; Grenouillet, F; Larosa, F; Limat, S; Muret, P | 1 |
| Morris, AM | 1 |
| Chandrasekar, P; Connelly, N; Cornely, OA; Duarte, RF; Haider, S; Helfgott, D; Kartsonis, N; Langston, A; Laverdiere, M; López-Jiménez, J; Ma, L; Perfect, J; van Iersel, ML; Waskin, H | 1 |
| Frauenfelder, T; Gerber, B; Köppel, J; Manz, MG; Nair, G; Nguyen-Kim, TD; Paul, M; Schanz, U | 1 |
| Duettmann, W; Hoenigl, M; Huber-Krassnitzer, B; Krause, R; Prattes, J; Prueller, F; Raggam, RB; Seeber, K; Theiler, G; Wagner, J; Wölfler, A; Zollner-Schwetz, I | 1 |
| Kim, JH; Williams, K | 1 |
| Castanheira, M; Farrell, DJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Choi, SJ; Kang, DY; Oh, SY; Ryu, CK | 1 |
| Jung, DS; Kontoyiannis, DP; Tverdek, FP | 1 |
| Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F | 1 |
| Chen, J; Hu, J; Huang, H; Huang, X; Jin, J; Li, J; Li, Y; Liang, Y; Ma, J; Sun, Y; Wang, C; Wang, J; Wu, D; Xiao, Y; Yu, K | 1 |
| Andes, DR; Lepak, AJ | 1 |
| Al-Hatmi, AM; Bonifaz, A; de Hoog, GS; Garcia-Carmona, K; Meis, JF; van Diepeningen, AD; Vazquez-Maya, L | 1 |
| Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kan, LP; Kao, WY; Lin, HA; Lin, JC; Lin, TY; Wang, CH; Wang, NC; Wu, YY | 1 |
| Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ | 1 |
| Mouton, JW; Seyedmousavi, S; Verweij, PE | 1 |
| Fan, H; Wang, JF; Xue, Y; Zhu, XB | 1 |
| Marcella, SW; Sung, AH; Xie, Y | 1 |
| Ain, Q; Pandey, OP; Pandey, SK; Sengupta, SK | 1 |
| McKeage, K | 1 |
| Böhme, A; Cornely, OA; Schmitt-Hoffmann, A; Ullmann, AJ | 1 |
| Guarascio, AJ; Slain, D | 1 |
| Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Handgretinger, R; Hartmann, U; Müller, I; Schulz, A; Schwarze, CP | 1 |
| Hochhaus, A; Schnetzke, U; Scholl, S; Schrenk, KG; Stegemann, K; von Lilienfeld-Toal, M | 1 |
| Traynor, K | 1 |
| Han, M; Huang, H; Huang, X; Ji, Y; Meng, F; Ren, H; Shen, Z; Sun, Y; Wang, C; Wu, D; Yu, L; Zhang, X | 1 |
| Marr, K; Ostrander, D; Shoham, S | 1 |
| Björkholm, M; Blennow, O; Cederlund, K; Dahlén, T; Kalin, M; Ljungman, P; Nordlander, A | 1 |
| Healy, JR; Kraft, WK; Moore, JN | 1 |
| Bagatell, R; Bosse, KR; Fisher, BT; Martino, J | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR | 1 |
| Caddell, R; Craig, M; Cumpston, A; Hamadani, M; Kanate, AS; Lu, X; Shillingburg, A; Wen, S | 1 |
| Ananda-Rajah, MR; Kontoyiannis, D | 1 |
| Li, R; Wan, Z; Yao, L; Yu, J | 1 |
| Chitasombat, MN; Kontoyiannis, DP | 1 |
| Couriel, DR; Kauffman, CA; Miceli, MH; Perissinotti, AJ | 1 |
| Béraud, G; Cabié, A; Coyo, C; Desbois, N; Quist, D; Rozé, B; Savorit, L | 1 |
| Abdul Halim, NA; Tan, BH; Wong, GC | 1 |
| Pagano, L; Tumbarello, M | 1 |
| Borthakur, G; Brown, Y; Cortes, J; Jabbour, E; Kantarjian, H; Konopleva, M; Mattiuzzi, G; Pierce, S; Yilmaz, M | 1 |
| Back, H; Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kang, S; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, EK; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
| Arechavala, A; Carrillo-Muñoz, AJ; Eraso, E; Giusiano, G; Jauregizar, N; Negroni, R; Quindós, G; Tur-Tur, C | 1 |
| Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, HJ; Kim, SH; Kim, YJ; Lee, DG; Lee, HJ; Min, WS; Park, SH; Yoo, JH | 1 |
| Berger, L; Brannelly, LA; Skerratt, LF | 1 |
| Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA | 1 |
| Cha, K; Chae, H; Cho, SY; Kim, HJ; Kim, M; Kim, Y; Kim, YJ; Lee, DG; Lee, S; Yu, H | 1 |
| Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW | 1 |
| Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF | 1 |
| Capilla, J; Guarro, J; Mayayo, E; Thomson, P | 1 |
| Clark, NM; Grim, SA; Lynch, JP | 1 |
| Abd El-Mawgoude, HK; Hemdan, MM | 1 |
| Blume, O; Cabanillas Stanchi, KM; Döring, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Hartmann, U; Heinz, WJ; Klinker, H; Lang, P | 1 |
| Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ | 1 |
| Annaert, P; Augustijns, P; Bica, AM; Colita, A; Mols, R; Peersman, N; Spriet, I; Vanstraelen, K; Vermeersch, P | 1 |
| Alffenaar, JW; Brouwers, CH; Kosterink, JG; Span, LF; Uges, DR; van den Heuvel, ER; van der Elst, KC; van der Werf, TS; van Wanrooy, MJ | 1 |
| Aguilar-Zapata, D; Petraitiene, R; Petraitis, V | 1 |
| Hall, RG; Payne, KD | 1 |
| Slavin, MA; Thursky, KA | 1 |
| Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B | 1 |
| Delarze, E; Sanglard, D | 1 |
| Azzopardi, M; Chambers, D; Chau, C; Hopkins, P; Robinson, CL; Yerkovich, ST | 1 |
| Capilla, J; Guarro, J; Mayayo, E; Paredes, K | 1 |
| Gallagher, S; Hashemzadeh, M; Peyton, LR | 1 |
| Annino, L; Arcioni, F; Bertaina, A; Carotti, A; Caselli, D; Cassetta, MI; Cerchiara, E; Chierichini, A; Cupelli, L; Del Principe, MI; Di Gioia, M; Fallani, S; Fanci, R; Girmenia, C; Mariotti, B; Mengarelli, A; Minotti, C; Novelli, A; Perriello, V; Piedimonte, M; Proia, A; Ribersani, M; Spadea, A; Torelli, GF | 1 |
| Díaz-Torres, E; Fuentes-Benítes, A; González-Calderón, D; González-Romero, C; Jauregui-Rodríguez, B; Mejía-Dionicio, MG; Morales-Reza, MA; Morales-Rodríguez, M; Ramírez-Villalva, A | 1 |
| Li, H; Li, S; Ma, X; Tang, B; Tang, P; Wu, D; Xu, K | 1 |
| Temesgen, Z; Walker, RC; Zeuli, JD | 1 |
| Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J | 1 |
| Lanternier, FL; Lortholary, O; Pilmis, B | 1 |
| Antypenko, LM; Fedyunina, NS; Karpenko, OV; Katsev, AM; Kovalenko, SI; Novikov, VP | 1 |
| Annaert, P; Augustijns, P; Hoenigl, M; Lagrou, K; Maertens, J; Mols, R; Peersman, N; Prattes, J; Schoemans, H; Spriet, I; Theunissen, K; Vanstraelen, K; Vermeersch, P | 1 |
| Ceesay, MM; Couchman, L; Flanagan, RJ; Pagliuca, A; Smith, M; Wade, J | 1 |
| Azie, N; Cornely, OA; Engelhardt, M; Kovanda, L; Lee, M; Maher, R; Ostrosky-Zeichner, L; Perfect, JR; Queiroz-Telles, F; Rendon, A; Ribeiro Dos Santos, R; Thompson, GR; Vazquez, JA | 1 |
| Bang, SM; Cho, JY; Choe, PG; Kim, EJ; Kim, ES; Kim, HB; Kim, I; Kim, NJ; Koh, Y; Lee, JO; Oh, MD; Park, SI; Park, WB; Song, KH; Song, SH; Yoon, S; Yoon, SH; Yu, KS | 1 |
| Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W | 1 |
| Duettmann, W; Hoenigl, M; Prattes, J | 1 |
| Buchan, BW; Cockerham, L; Feldman, R; Huang, AM; Lu, Z | 1 |
| Ananda-Rajah, MR; Bajel, A; Chen, SC; Grigg, A; Haywood, P; Jeong, W; Kong, DC; Lindsay, J; Peleg, AY; Ritchie, D; Seymour, JF; Shanmuganathan, N; Slavin, MA; Urbancic, K | 1 |
| Bond, SE; Lindsay, PJ; Marriott, DJ; Miyakis, S; Norris, R | 1 |
| Bubalo, JS; Lewis, JS; Pham, AN | 1 |
| Blaeschke, F; Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Heinz, WJ; Klinker, H; Schwarze, CP | 1 |
| Arnan, M; Ayats, J; Cuenca-Estrella, M; Duarte, RF; Patiño, B; Sánchez-Ortega, I; Sureda, A | 1 |
| Chang, YL; Chen, YL; Heitman, J; Wellington, M; Yu, SJ | 1 |
| Coignard-Biehler, H; Jullien, V; Lanternier, F; Lortholary, O; Pilmis, B; Rouzaud, C | 1 |
| Freeman, AF; Hallahan, CW; Holland, SM; Jancel, T; Kim, T; Penzak, SR; Shaw, PA | 1 |
| Abu Saleh, O; Mahmood, M; Sohail, MR | 1 |
| Bourassa, L; O'Brien, KD; Rakita, RM | 1 |
| Blaeschke, F; Cabanillas Stanchi, KM; Döring, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Heinz, WJ; Lang, P; Müller, I; Queudeville, M; Schlegel, P | 1 |
| Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M | 1 |
| Barcia, M; De-Domingo-Barón, B; Pardo-Sánchez, F; Rodríguez-Ares, T; Romero-Jung, P; Touriño-Peralba, R | 1 |
| Fille, M; Hausdorfer, J; Hinterberger, G; Lass-Flörl, C; Mayr, A; Perkhofer, S; Speth, C | 1 |
| Rachwalski, EJ; Scheetz, MH; Wieczorkiewicz, JT | 1 |
| Fleck, R; Hof, H | 1 |
| Groll, AH; Lehrnbecher, T | 1 |
| Hoppe-Tichy, T; Lichtenstern, C; Störzinger, D; Swoboda, S; Weigand, MA | 1 |
| Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
| Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB | 1 |
| Geria, AN; Scheinfeld, NS | 1 |
| Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P | 1 |
| Alexander, BD; Daly, JS; Graybill, JR; Hardalo, CJ; Patino, H; Perfect, JR; Restrepo, A; Tobón, AM | 1 |
| Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV | 1 |
| AbuTarif, M; Angulo, D; Cornely, OA; Krishna, G; Martinho, M; Xuan, F | 1 |
| Buchta, V; Vale-Silva, LA; Vejsova, M | 1 |
| Imai, K; Kobayashi, D; Kogawa, K; Nonoyama, S; Nozaki, M; Sugita, T; Tokimatsu, I; Tsuji, Y | 1 |
| KLIGMAN, AM; ROSENSWEIG, W | 1 |
| Cornely, OA; Farowski, F; Kohl, V; Müller, C | 1 |
| Billaud, EM; Denning, DW; Hope, WW; Lestner, J | 1 |
| Cleveland, KO; Lacasse, A | 1 |
| Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K | 1 |
| Bijie, H; Diekema, DJ; Dzierzanowska, D; Gibbs, DL; Klimko, NN; Letscher-Bru, V; Lisalova, M; Muehlethaler, K; Newell, VA; Pfaller, MA; Rennison, C; Zaidi, M | 1 |
| Alastruey-Izquierdo, A; Cuenca-Estrella, M; Hazar, V; Ogunc, D; Ongut, G; Ozhak-Baysan, B; Rodriguez-Tudela, JL; Tezcan, G; Yildiran, ST | 1 |
| Chang, BP; Chen, YC; Huang, FY; Lee, MD; Lin, CC; Sheu, JC; Sun, PL; Tsai, JD; Tsai, TC | 1 |
| Collins, CD; Ellis, JJ; Kaul, DR | 1 |
| Filioti, I; Iosifidis, E; Roilides, E | 1 |
| Guarro, J; Pastor, FJ; Rodríguez, MM; Serena, C | 2 |
| Maesaki, S; Tarumoto, N | 1 |
| Niki, Y | 2 |
| Fujii, Y; Inase, N; Yoshizawa, Y | 1 |
| Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL | 1 |
| Bouza, E; Guinea, J | 1 |
| Guarro, J; Mariné, M; Pastor, FJ | 1 |
| Almirante, B; Pemán, J | 1 |
| González, GM | 1 |
| Fothergill, AW; Rinaldi, MG; Sutton, DA | 1 |
| Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K | 1 |
| De Sarro, A; Fera, MT; La Camera, E | 2 |
| Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T | 1 |
| Aralikatti, A; Dean, S; Mitra, A; Savant, V; Shah, S | 1 |
| Morris, MI | 1 |
| Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M | 1 |
| Arsenis, G; Kafetzis, D; Lebessi, E; Pasparakis, D; Stripeli, F; Tsolia, M; Velegraki, A | 1 |
| Baird, K; Cowen, EW; Gea-Banacloche, J; Mitchell, S; Patel, AR; Pavletic, SZ; Turner, ML; Wise, B | 1 |
| Alaggio, R; Alessia, B; Cesaro, S; Gamba, P; Marinello, S; Putti, MC; Rossi, L; Toffolutti, T | 1 |
| Adams, AI; Bergold, AM; Meneghini, LZ; Morimoto, LN | 1 |
| Naeger-Murphy, N; Pile, JC | 1 |
| Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR | 1 |
| Drew, RH; Perfect, JR; Smith, WJ | 1 |
| Dorsey, SA; Lewis, JS; Patterson, TF; Pennick, G; Rinaldi, MG; Thompson, GR | 1 |
| Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
| Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
| Drew, RH; Perfect, JR; Wilson, DT | 1 |
| Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC | 1 |
| Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K | 1 |
| Cociglio, M; Eiden, C; Hansel-Esteller, S; Hillaire-Buys, D; Margueritte, G; Palenzuela, G; Peyriere, H | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Araujo, R; Costa-de-Oliveira, S; Coutinho, I; Pina-Vaz, C; Rodrigues, AG | 1 |
| Bluemel, A; Ghebremedhin, B; Koenig, B; Koenig, W; Neumann, KH | 1 |
| Maschmeyer, G | 1 |
| Fothergill, A; Patterson, TF; Sutton, DA; Thompson, GR; Wiederhold, NP | 1 |
| Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J | 1 |
| Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T | 1 |
| Ayats, J; Cabellos, C; Fernandez-Viladrich, P; Ferran, E; Font, F; Garcia-Vidal, C | 1 |
| Engel, P; Herbrecht, R; Levêque, D; Nivoix, Y; Ubeaud-Sequier, G | 1 |
| Dinc, BM; Kalkanci, A; Kekilli, M; Kurt, M; Odemis, B; Oztas, E; Parlak, E; Sasmaz, N | 1 |
| Autthateinchai, R; Ikeda, R; Mekha, N; Nishikawa, A; Poonwan, N; Sawanpanyalert, P; Sugita, T | 1 |
| Furlanut, M; Pea, F; Viale, P | 1 |
| Aggermann, T; Binder, S; Haas, P; Hochwarter, A; Krepler, K | 1 |
| Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF | 1 |
| Acharya, NR; Hong, K; Lee, S; Loh, AR; Mannis, M | 1 |
| Lass-Flörl, C; Perkhofer, S | 1 |
| Fothergill, AW; Hickey, PW; Rinaldi, MG; Schmidt, HJ; Sutton, DA; Walsh, TJ; Wickes, BL | 1 |
| Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L | 1 |
| Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G | 1 |
| Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S | 1 |
| Bougnoux, ME; Buzyn, A; Elie, C; Jullien, V; Lanternier, F; Lebeaux, D; Lecuit, M; Lortholary, O; Suarez, F; Viard, JP | 1 |
| Amábile-Cuevas, CF; Arredondo-García, JL | 1 |
| Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S | 1 |
| Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M | 1 |
| Besterman, JM; Diekema, DJ; Georgopapadakou, N; Martell, LA; Messer, SA; Pfaller, MA | 1 |
| Carreras, E; Casado, MA; de la Cámara, R; Grau, S; Jarque, I; Sabater, FJ; Sanz, MA | 2 |
| Marriott, D; Miyakis, S; Ray, J; van Hal, SJ | 1 |
| Abduljalil, K; Cornely, OA; Fuhr, U; Hallek, M; Kohl, V; Müller, C; Rüping, MJ; Scheid, C; Vehreschild, JJ | 1 |
| Hansel-Esteller, S; Selvy, N; Villiet, M | 1 |
| Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A | 1 |
| Böhme, A; Cornely, OA; Drzisga, I; Frommolt, P; Hallek, M; Harnischmacher, U; Mousset, S; Müller, C; Rüping, MJ; Vehreschild, JJ; Wassmer, G | 1 |
| Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D | 1 |
| Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Franke, B; Troke, PF | 1 |
| Lewis, JS; Thompson, GR | 1 |
| Drusano, GL | 1 |
| Hoffman, J; Jelliffe, R; Kovacs, A; Neely, M; Rushing, T | 1 |
| Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L | 1 |
| Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF | 1 |
| Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T | 1 |
| AbuTarif, MA; Krishna, G; Statkevich, P | 1 |
| Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M | 1 |
| Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Rodríguez, MM; Salas, V | 1 |
| Cornely, OA; Rüping, MJ; Vehreschild, JJ | 1 |
| Nehls, S; Ogawa, GS; Pariseau, B; Romanelli, AM; Sutton, DA; Wickes, BL | 1 |
| Chandrasekar, PH; Cronin, S | 1 |
| Bocanegra, R; Graybill, JR; Najvar, LK; Patterson, TF; Wiederhold, NP | 1 |
| Celik, U; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Nguyen, ML; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A; Yousem, SA | 1 |
| Hsiao, CH; Lai, CH; Ma, DH; Tan, HY; Wu, PC | 1 |
| Goldani, LZ; Pasqualotto, AC; Thiele, KO | 1 |
| Collins, CD; DePestel, DD; Mackler, ER; Nemerovski, CW; Stevenson, JG; Welch, KS | 1 |
| Miharu, M; Osumi, T; Shima, H; Shimada, H; Takahashi, T | 1 |
| Li, H; Lu, Q; Wan, Z; Zhang, J | 1 |
| Basara, N; Bierbach, U; Frenzel, K; Lange, T; Mauz-Körholz, C; Michael, C; Niederwieser, D; Preiss, R | 2 |
| Buzina, W; Horré, R; Lackner, M; Tintelnot, K | 1 |
| Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K | 1 |
| FISHER, JK; HOPKINS, JG | 1 |
| Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J | 1 |
| Ailani, H; Cohen, EJ; Eagle, RC; Hammersmith, KM; Rapuano, CJ; Yildiz, EH | 1 |
| Babatz, J; Ehninger, G; Illmer, T; Pursche, S; Schaich, M; Schuler, U; Stölzel, F | 1 |
| Baert, K; Beernaert, L; de Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; van Rooij, P; Van Waeyenberghe, L | 1 |
| Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T | 1 |
| Bangard, C; Cornely, OA; Farowski, F; Hallek, M; Kreuzer, KA; Rüping, MJ; Sims, R; Steinbach, A; Stollorz, A; Vehreschild, JJ; Wisplinghoff, H | 1 |
| Greiner, RA; Imhof, A; Meier, Y; O'Sullivan, AK; Papadopoulos, G | 1 |
| Corey, M | 1 |
| Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL | 1 |
| Frick, MA; Guarner, ME; Martín Nalda, A; Nadal, CF; Soler-Palacín, P | 1 |
| Ito, E; Kamio, T; Kudo, K; Sasaki, S; Sato, T; Terui, K | 1 |
| Bartoni, K; Schiller, GJ; Territo, MC; Winston, DJ | 1 |
| Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Theuretzbacher, U | 1 |
| Elston, DM | 1 |
| Calvo, E; Guarro, J; Pastor, FJ | 1 |
| Odio, CM | 1 |
| Attarbaschi, A; Duerken, M; Garbino, J; Groll, AH; Gruhn, B; Kontny, U; Lehrnbecher, T; Lüer, S; Phillips, R; Scholz, J; Wagner, HJ; Wiesel, T | 1 |
| Colangelo, PM; Gobburu, JV; Jang, SH | 1 |
| Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE | 1 |
| Kagoshima, Y; Kamai, Y; Kobayashi, N; Konosu, T; Kubota, M; Mori, M; Shibayama, T; Suzuki, E | 1 |
| Thompson, GR; Wiederhold, NP | 1 |
| Arron, ST; Ibrahim, SF; Singer, JP | 1 |
| Bertz, H; Engelhardt, M; Hieke, S; Jung, M; König, A; Kümmerer, K; Neubauer, WC | 1 |
| Acharya, NR; Hong, KC; Krishnan, T; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Porco, TC; Prajna, L; Prajna, NV; Reddy, PR; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
| Kondori, N; Mattsby-Baltzer, I; Svensson, E | 1 |
| Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A | 1 |
| Lazzaro, C | 1 |
| Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F | 1 |
| Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y | 1 |
| Bienvenu, AL; Biswas, P; Caillot, D; Chachaty, E; Cornet, M; Greene, J; Grenouillet, F; Herbrecht, R; Lacroix, C; Lortholary, O; Obenga, G; Raad, I; Sitbon, K; Troke, P | 1 |
| Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R | 1 |
| Abecasis, M; Bilger, K; Bofarull, RM; Cordonnier, C; Cornely, OA; de la Cámara, R; Einsele, H; Faucher, C; Heussel, CP; Liakopoulou, E; Ljungman, P; Maertens, J; Olavarria, E; Pigneux, A; Pineau, M; Rovira, M; Ullmann, AJ; Weisser, M | 1 |
| Arrieta, AC; Driscoll, T; Groll, AH; Jafri, H; Klein, NJ; Lutsar, I; Milligan, PA; Schlamm, H; Walsh, TJ; Wood, ND | 1 |
| Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A | 1 |
| Arisawa, M; Fujii, T; Inagaki, Y; Kobayashi, K; Ohwada, J; Page, MG; Shimma, N; Tsukazaki, M; Umeda, I; Yamazaki, T | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Arnan, M; Duarte, RF; Encuentra, M; Fernández de Sevilla, A; Gudiol, C; Parody, R; Patiño, B; Peralta, T; Sánchez-Ortega, I | 1 |
| Wan, K; Wang, XL; Zhou, CH | 1 |
| Baert, K; Debacker, P; Ducatelle, R; Garner, TW; Haesebrouck, F; Martel, A; Pasmans, F; Van Rooij, P; Van Waeyenberghe, L; Vercauteren, G; Woeltjes, T | 1 |
| Fisher, C; Jones, RL; Judson, IR; Ratnayake, G; Scurr, M; Thway, K | 1 |
| Díaz-Llopis, M; Garcia-Delpech, S; Salom, D; Udaondo, P | 1 |
| Bleyzac, N; Goutelle, S; Larcher, R; Mialou, V; Padoin, C | 1 |
| Anandbabu, K; Basu, G; Devasia, A; Sundaram, M; Tamilarasi, V | 1 |
| Cárdenes, D; Carrillo-Muñoz, AJ; Eraso, E; Estivill, D; Giusiano, G; Guardia, C; Hernández-Molina, JM; Marcos-Arias, C; Ortiz-Maestro, O; Quindós, G; Santos, P; Tur-Tur, C | 1 |
| Guarro, J; Pastor, J; Ruíz-Cendoya, M | 1 |
| Accoceberry, I; Gabriel, F; Noel, T | 1 |
| Dranitsaris, G; Khoury, H | 1 |
| Esterly, JS; Fotis, M; Gorski, E; Postelnick, M; Scheetz, MH; Trifilio, S | 1 |
| Auffarth, GU; Dithmar, S; Thomas, BC; Völcker, HE; Zimmermann, S | 1 |
| DUGGAN, TL; MOONEY, JJ | 1 |
| Langston, AA; Mehta, AK | 1 |
| Cecil, JA; Wenzel, RP | 1 |
| Balestrazzi, A; Ciompi, L; Franceschini, R; Martone, G; Moramarco, A; Pichierri, P; Tosi, GM | 1 |
| Arora, R; Goyal, J; Gupta, D; Kaur, R | 1 |
| Balasingham, A; Balasingham, S; Chalkias, S; Saul, Z; Sutton, DA; Wickes, BL | 1 |
| Baker, K; Klepser, ME; Valente, C; Zoller, E | 1 |
| Aversa, F; Cesaro, S; Milano, GM | 1 |
| Egerer, G; Geist, MJ | 1 |
| Andreesen, R; Hahn, J; Holler, E; Reichle, A; Stifel, F | 1 |
| Lipp, HP | 2 |
| Hoppe-Tichy, T; Lichtenstern, C; Störzinger, D; Weigand, MA | 1 |
| Brüggemann, RJ; Burger, DM; van der Linden, JW; Verweij, PE; Warris, A | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA | 1 |
| Bryan, J; Maertens, J | 1 |
| Al-Badriyeh, D; Heng, SC; Kong, DC; Neoh, CF; Slavin, M; Stewart, K | 1 |
| Böhme, A; Heinz, WJ; Silling, G | 1 |
| Charles, JF; Daikh, DI; Eberle, C; Rooney, T | 1 |
| Ciecko, SC; Scher, R | 1 |
| Berger, P; Caillot, D; Dupont, B; Gangneux, JP; Herbrecht, R; Lafuma, A; Michallet, M; Moreau, P; O'Sullivan, AK; Ribaud, P | 1 |
| Sheng, C; Zhang, W | 1 |
| Cuenca-Estrella, M | 1 |
| Askari, E; Cáceres Agra, JJ; Jarque, I; Nicolás Franco, S | 1 |
| Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH | 1 |
| Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M | 1 |
| Bryant, AM; Craig, M; Cumpston, A; Slain, D | 1 |
| Blanche, S; Bougnoux, ME; Catherinot, E; Coignard, H; Debourgogne, A; Garcia-Hermoso, D; Hassouni, N; Lecuit, M; Lortholary, O; Machouart, M; Rivier, A; Salmon, A | 1 |
| Bose, P; Greenfield, RA; Holter, JL; Parekh, HD | 1 |
| Cornely, OA; Ullmann, AJ | 2 |
| Benjamin, DK; Cohen-Wolkowiez, M; Watt, K | 1 |
| Cordonnier, C; Cornely, OA; Einsele, H; Ljungman, P; Maertens, J; Rovira, M | 1 |
| Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS | 1 |
| Deuel, T; Folkerth, R; Jiang, JX; Kesari, S; Lechpammer, M; Marty, FM; Milner, DA; Rosow, L; Zamani, AA | 1 |
| Davis, JL; Goldstein, SC; Lombardi, LR; Miano, TA; Mitra, N; Morgan, SC; Vardhanabhuti, S; Vozniak, JM | 1 |
| Sheng, CQ; Wang, SZ; Zhang, WN | 1 |
| Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T | 1 |
| Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
| Garnacho-Montero, J; Jiménez Parrilla, F | 1 |
| Jarque, I; Salavert, M | 2 |
| Huang, CY; Sun, PL; Tseng, HK | 1 |
| Daneshgar, F; Khodabande, A; Siatiri, H; Siatiri, N | 1 |
| Katragkou, A; Roilides, E | 1 |
| Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A | 1 |
| Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR | 1 |
| He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM | 1 |
| Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M | 1 |
| Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A | 1 |
| Blyth, CC | 1 |
| Jullien, V | 1 |
| Ceballos, P; Cociglio, M; Eiden, C; Eymard-Duvernay, S; Fegueux, N; Hillaire-Buys, D; Le Falher, G; Meniane, JC; Peyrière, H; Reynes, J | 1 |
| Green, MR; Woolery, JE | 2 |
| Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L | 1 |
| Debourgogne, A; Gérard, A; Lévy, B; Machouart, M; Perny, J; Rivier, A; Thivillier, C | 1 |
| Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R | 1 |
| Kharb, R; Sharma, PC; Yar, MS | 1 |
| Alivanis, P; Aperis, G | 1 |
| Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA | 1 |
| Williams, D | 1 |
| Chen, W; Li, YX; Li, ZM; Liu, TW; Mao, MZ; Wang, SH; Yu, SJ; Zhou, YY | 1 |
| Blanche, S; Bougnoux, ME; Elie, C; Gerin, M; Jullien, V; Lanternier, F; Lortholary, O; Mahlaoui, N | 1 |
| Hockey, HP; Hope, WW; Troke, PF | 1 |
| Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK | 1 |
| Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL | 1 |
| Dickmeyer, NJ; Kiel, PJ | 1 |
| Atta, KF | 1 |
| Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C | 1 |
| Aneja, DK; Aneja, KR; Arora, S; Hussain, K; Lohan, P; Prakash, O; Ranjan, P; Sharma, C | 1 |
| Al Abdallah, Q; Campoli, P; Fielhaber, JA; Filler, SG; Kristof, AS; Laverdiere, M; Robitaille, R; Sheppard, DC; Solis, NV | 1 |
| Haagsma, CJ; Hendrix, R; Ruinemans, GM | 1 |
| Gubbins, PO | 1 |
| de Hoog, GS; Hell, M; Lackner, M; Neureiter, J; Presterl, E; Willinger, B; Wojna, A | 1 |
| Cui, Y; Jin, C; Li, X; Wu, N | 1 |
| Caira, M; Leone, G; Pagano, L; Trecarichi, EM; Tumbarello, M | 1 |
| Pandey, OP; Sengupta, SK; Singh, AK | 1 |
| Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I | 1 |
| Blanche, S; Chosidow, O; Epaulard, O; Leccia, MT; Lortholary, O; Mamzer-Bruneel, MF; Ravaud, P; Thiebaut, A; Villier, C | 1 |
| Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M | 1 |
| Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J | 1 |
| Cendejas-Bueno, E; Cuenca-Estrella, M; Cuesta, I; García Rodríguez, J; Gómez-López, A; Gutiérrez-Altés, A; Rodríguez-Tudela, JL | 1 |
| Alimena, G; Breccia, M; Capria, S; Cartoni, C; Foà, R; Frustaci, AM; Gentile, G; Girmenia, C; Latagliata, R; Loglisci, G; Matturro, A; Meloni, G; Micozzi, A; Minotti, C; Trisolini, SM | 1 |
| Muralikrishna, A; Padmaja, A; Padmavathi, V; Rajasekhar, C | 1 |
| Lass-Flörl, C | 1 |
| Chiche, L; Dicostanzo, MP; Durand, JM; Eldin, C; Harle, JR; Ranque, S; Thomas, G | 1 |
| de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P | 1 |
| Kontoyiannis, DP | 1 |
| Chan, C; Chen, J; Colantonio, D; Seto, W | 1 |
| Feng, AM; Wei, JY; Yu, WJ | 1 |
| Felton, TW; Gomez-Lopez, A; Hope, WW; Howard, SJ | 1 |
| Hamada, Y; Kuroyama, M; Seto, Y; Yago, K | 1 |
| Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L | 1 |
| Cornely, OA; Farowski, F; Fuhr, U; Hallek, M; Kohl, V; Kreuzer, KA; Müller, C; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Cornely, OA; Heinz, W; Helfgott, D; Huyck, S; Krishna, G; Langston, A; Ma, L; McCarthy, MC; Vehreschild, JJ; Vehreschild, MJ | 1 |
| Fortún, J | 1 |
| Almajan, GL; Bancescu, G; Barbuceanu, F; Barbuceanu, SF; Draghici, C; Saramet, G | 1 |
| Ahmad, S; Al-Ghimlas, F; Al-Mutairi, S; Chandy, R; Guarro, J; Joseph, L; Khan, Z; Sutton, DA | 1 |
| Chen, F; Chen, Y; Hu, J; Huang, X; Jie, J; Liang, Y; Liu, T; Shen, Z; Wang, F; Wang, J; Wang, S; Yu, K; Yu, L | 1 |
| Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y | 1 |
| Acharya, NR; Krishnan, T; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Vaitilingam, CM; Zegans, ME | 1 |
| Shen, YF; Sun, HL; Zhou, X | 1 |
| Mossad, SB | 1 |
| Dolton, MJ; Marriott, D; McLachlan, AJ; Ray, JE | 1 |
| Newton, EJ | 1 |
| Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD | 1 |
| Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR | 1 |
| Hoenigl, M; Krause, R; Raggam, RB; Salzer, HJ; Seeber, K; Sill, H; Strohmeier, AT; Valentin, A; Valentin, T; Wölfler, A; Zollner-Schwetz, I | 1 |
| Arron, ST; Binstock, M; Boettger, R; Boker, A; Glidden, DV; Golden, JA; Metchnikoff, C; Singer, JP | 1 |
| Campbell, WN; Fothergill, AW; Keshtkar-Jahromi, M; McTighe, AH; Segalman, KA | 1 |
| Eberhard, R; Fleischhauer, J; Kocher, C; Trachsler, S | 1 |
| Aebi, C; Ammann, RA; Bernhard, S; Diepold, M; Kernland Lang, K; Leibundgut, K; Lüer, S | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Yang, G; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Drogari-Apiranthitou, M; Grammatikou, M; Kanioura, L; Mantopoulou, FD; Mitroussia-Ziouva, A; Petrikkos, G; Skiada, A; Tsakris, A; Vrioni, G | 1 |
| Carroll, KC; Illei, PB; Lederman, HM; Marr, KA; Meriden, Z; Riedel, S; Villa, K; Zhang, SX | 1 |
| Chen, SC; Lawrence, C; Lemos, BD; Marshall Lyon, G; Spratt, M; Veledar, E; Zwald, FO | 1 |
| Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J | 1 |
| Bijleveld, YA; Brüggemann, RJ; Crombag, MR; Huisman, C; Kemper, EM | 1 |
| Antin, JH; Armand, P; Baden, LR; Hammond, SP; Koo, S; Kubiak, DW; Marty, FM | 1 |
| Kuo, CH; Kuo, HP; Lin, SC; Lin, SW; Liu, HY; Wu, UI; Yao, M | 1 |
| Andes, D; Lepak, A | 1 |
| Bille, J; Bolay, S; Buclin, T; Calandra, T; Csajka, C; Marchetti, O; Pascual, A | 1 |
| Best, L; Champlin, RE; Georgiadou, SP; Kontoyiannis, DP; Lewis, RE; Torres, HA | 1 |
| Aigner, M; Auberger, J; Clausen, J; Gastl, G; Lass-Flörl, C; Nachbaur, D | 1 |
| Abdi, RF; Al-Tawfiq, JA; Tarazi, AE | 1 |
| Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M | 1 |
| Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W | 1 |
| Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, LG; Ray, JE | 1 |
| Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
| Baden, LR; Boukedes, S; Camp, PC; Dietzek, A; Fuhlbrigge, AL; Goldberg, HJ; Issa, NC; Koo, S; Kubiak, DW; Marty, FM | 1 |
| Caira, M; Cuenca-Estrella, M; Pagano, L | 1 |
| Campo, M; Chaftari, AM; Hachem, RY; Jiang, Y; Kassis, C; Prince, RA; Raad, II; Ramos, E; Wang, W | 1 |
| Graham, ML; Matthias, KR; Nix, DE; Peloquin, CA | 1 |
| Damu, GL; Geng, RX; Lv, JS; Wang, Y; Yang, DC; Zhou, CH | 1 |
| Alsamad, IA; Botterel, F; Coste, A; Papon, JF; Pruliere-Escabasse, V; Toussain, G; Zerah-Lancner, F | 1 |
| Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, L; Ray, JE | 1 |
| Girmenia, C; Iori, AP | 1 |
| Atkinson, G; Lee, GA; McLintock, CA | 1 |
| Benjamin, DK; Boano, E; Cohen-Wolkowiez, M; Jacqz-Aigrain, E; Manzoni, P; Rizzollo, S; Watt, K | 1 |
| Aversa, F; Busca, A; Caira, M; Candoni, A; Caramatti, C; Castagnola, C; Cattaneo, C; De Paolis, MR; Delia, M; Di Blasi, R; Di Caprio, L; Fanci, R; Garzia, M; Martino, B; Melillo, L; Mitra, ME; Nadali, G; Nosari, A; Pagano, L; Picardi, M; Potenza, L; Salutari, P; Trecarichi, EM; Tumbarello, M; Verga, L; Vianelli, N | 1 |
| Falcone, EL; Holland, SM | 1 |
| Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K | 1 |
| Chohan, ZH; Sumrra, SH | 1 |
| Arnan, M; Bermúdez, A; Caballero, T; Duarte, RF; Montes, C; Patiño, B; Sánchez-Ortega, I; Vázquez, L; Yáñez, L | 1 |
| Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL | 1 |
| Aversa, F; Busca, A; Candoni, A; Cesaro, S; Girmenia, C; Luppi, M; Nosari, AM; Pagano, L; Rossi, G; Venditti, A | 1 |
| Lu, HZ; Shen, YZ; Wang, ZY | 1 |
| Bryant, AM; Craig, M; Cumpston, A; Hamadani, M; Ross, AL; Slain, D | 1 |
| Berzins, IK; Naples, LM; Poll, CP | 1 |
| Döring, M; Erbacher, A; Handgretinger, R; Johann, PD; Kimmig, A; Lang, P; Müller, C; Müller, I; Schwarze, CP | 1 |
| Ananda-Rajah, MR; Grigg, A; Slavin, MA | 1 |
| Chen, J; Liang, L; Liu, D | 1 |
| Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J | 1 |
| Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C | 1 |
| Ding, Y; Diong, CP; Hsu, LY; Jin, J; Lim, ZY; Low, CY; Ong, WC; Wong, E | 1 |
| Estes, LL; Wilson, JW; Zeuli, JD | 1 |
| Hunt, S; Papadopoulos, G; Prasad, M | 1 |
| Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T | 1 |
| Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ | 1 |
| Barberán, J; Carreras, E; Jarque, I; Mensa, J; Serrano, D; Vázquez, L | 1 |
| Allen, PB; Baer, MR; Kleinberg, ME; Koka, R | 1 |
| Lilly, CM; Luke, DR; Mayer, T; Meisner, J; Ranauro, P; Welch, VL | 1 |
| Yoshida, M | 1 |
| Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW | 1 |
| Koparir, M; Koparir, P; Orek, C; Sarac, K | 1 |
| Chandrasekar, P; Jacinto, PL | 1 |
| Stevens, DA | 1 |
| Banerjee, D; Khetan, A; Mandal, SM; Saha, S; Sengupta, J | 1 |
| Golden, JA; Kukreja, J; Leard, LE; Sayah, DM; Schwartz, BS; Singer, JP | 1 |
| Greenberg, RN; Martin, CA; Roberts, S | 1 |
| Garbino, J; Hirschel, B | 1 |
| Baglivo, E; Baligvo, E; Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Ondrusova, A; Rohner, P | 1 |
| Cornely, OA; Karthaus, M; Ullmann, AJ | 1 |
| Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM | 1 |
| Falk, R; Polacheck, I; Shapiro, M; Wolf, DG | 1 |
| De Hoog, GS; Hatemi, G; Kantarcioğlu, AS; Mandel, NM; Yücel, A | 1 |
| Adderson, EE; Andreansky, M; Luján-Zilbermann, J; Rodriguez, CA; Woodard, P | 1 |
| Chapman, SW; Cleary, JD; Pearson, MM; Rogers, PD | 1 |
| Chan, J | 1 |
| Kontoyiannis, DP; Mantadakis, E; Samonis, G | 1 |
| Holzgrabe, U; Schäfer-Korting, M | 1 |
| Bocanegra, R; Gonzalez, GM; Graybill, JR; Hernandez, S; Najvar, LK | 1 |
| Gea-Banacloche, JC; Glasmacher, A; Groll, AH; Just-Nuebling, G; Maschmeyer, G; Walsh, TJ | 1 |
| Sutton, DA | 1 |
| Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A | 1 |
| Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V | 1 |
| Girmenia, C; Martino, P | 1 |
| Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Lutsar, I; Roffey, S; Troke, P | 1 |
| Schäfer-Korting, M | 1 |
| Gupta, AK; Tomas, E | 1 |
| Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV | 1 |
| KADEN, R | 1 |
| LEQUES, B; PAGES, F; VESVAL, P | 1 |
| GOLDMAN, L | 1 |
| Andes, D | 1 |
| Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD | 1 |
| Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C | 1 |
| Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J | 1 |
| Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
| Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH | 1 |
| Arechavala, A; Bianchi, MH; Helou, SH; Negroni, R; Petri, N; Robles, AM | 1 |
| VANBREUSEGHEM, R | 1 |
| Baden, LR; Cosimi, LA; Marty, FM | 1 |
| Gothard, P; Rogers, TR | 1 |
| Rubin, ZA; Somani, J | 1 |
| Alfonso, EC; Giaconi, JA; Marangon, FB; Miller, D | 2 |
| Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M | 1 |
| Bocanegra, R; Graybill, JR; Johnson, E; Loebenberg, D; Najvar, LK | 1 |
| Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L | 1 |
| Cordonnier, C | 1 |
| Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR | 1 |
| Aoun, M | 1 |
| Alexopoulos, EC; Gaitanis, G; Kritikou, S; Velegraki, A | 1 |
| Herbrecht, R | 2 |
| Bigley, VH; Duarte, RF; Gosling, RD; Kibbler, CC; Potter, M; Seaton, S | 1 |
| Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE | 1 |
| Klastersky, J | 1 |
| Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I | 1 |
| Wingard, JR | 1 |
| Comair, Y; Kanafani, ZA; Kanj, SS | 1 |
| Mastromarino, A; Polizzi, A; Saccà, SC; Siniscalchi, C | 1 |
| Agrawal, AK; Sherman, LK | 1 |
| Perfect, JR | 2 |
| Marr, K | 1 |
| Bareau, B; Camus, C; Tattevin, P | 1 |
| Danaher, PJ | 1 |
| Lowry, CM; Marty, FM | 1 |
| Balwierz, W | 1 |
| Al-Abdely, HM; Al-Tawfiq, JA; Alkhunaizi, AM; Hassounah, M; Rinaldi, MG; Sutton, DA | 1 |
| Chen, A; Sobel, JD | 1 |
| Björkholm, M; Cherif, H; Chryssanthou, E; Kalin, M; Petrini, B | 1 |
| Ausma, J; Backx, LJ; Borgers, M; Corens, D; De Groot, A; Heeres, J; Marichal, PJ; Meerpoel, L; Odds, FC; Oris, M; Van Breda, A; Van der Veken, LJ; van Dorsselaer, P; Van Gerven, F; Vanden Bossche, HF; Vermuyten, KJ; Willemsens, GH; Woestenborghs, FA | 1 |
| Cudillo, L; de Fabritiis, P; Dentamaro, T; Girmenia, C; Picardi, A; Santilli, S; Tendas, A | 1 |
| Garbino, J; Lew, D; Rohner, P; Uckay, I; Van Delden, C | 1 |
| Batra, R; Gupta, AK; Kohli, Y | 1 |
| Mohammedi, I; Padoin, C; Piens, MA; Robert, D | 1 |
| Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M | 1 |
| Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P | 1 |
| Böhme, A; Haas, A; Maschmeyer, G | 1 |
| Berthou, C; Eveillard, JR; Ianoto, JC; Karam, A; Le Flohic, AM; Le Roy, JP; Misery, L; Quinio, D | 1 |
| Boisseau-Garsaud, AM; Calès-Quist, D; Desbois, N; Diedhou, A; Dutriaux, C; Saint-Cyr, I | 1 |
| Steinbach, WJ | 1 |
| Kofla, G; Ruhnke, M | 1 |
| Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD | 1 |
| Keady, S; Thacker, M | 1 |
| Fothergill, AW; González, GM; Loebenberg, D; Rinaldi, MG; Sutton, DA | 1 |
| Keating, GM | 1 |
| Morace, G; Polonelli, L | 1 |
| Benjamin, DK; Steinbach, WJ; Zaoutis, TE | 1 |
| Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Groll, AH; Walsh, TJ | 2 |
| Alexander, BD; Dodds Ashley, ES | 1 |
| Fohrer, C; Herbrecht, R; Letscher-Bru, V; Natarajan-Amé, S; Nivoix, Y | 1 |
| Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C | 1 |
| Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH | 1 |
| Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP | 1 |
| Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V | 1 |
| Chan-Tack, KM | 1 |
| Baker, CJ; Pannaraj, PS; Walsh, TJ | 1 |
| Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S | 1 |
| Colombo, GL; Morlotti, L; Serra, G | 1 |
| Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D | 1 |
| Chamilos, G; Kontoyiannis, DP | 1 |
| Chemaly, RF; Hachem, RY; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
| Chamilos, G; Kontoyiannis, DP; Lewis, RE | 1 |
| Burchardt, A; Corcoran, G; Cornely, OA; Courtney, R; Hachem, R; Kontoyiannis, DP; Krishna, G; Martinho, M; Raad, I; Töpelt, K; Ullmann, AJ; Wexler, D | 1 |
| Gøtzsche, PC; Johansen, HK; Jørgensen, KJ | 1 |
| Ellis, D; Harkness, J; Kwong, T; Marriott, D | 1 |
| Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV | 1 |
| Baccari, P; Fumagalli, L; Lazzarin, A; Magnani, P; Prigitano, A; Sagnelli, C | 1 |
| Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL | 1 |
| Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A | 1 |
| Al-Attar, A; Redett, RJ; Williams, CG | 1 |
| de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C | 1 |
| Agostinelli, C; Arpinati, M; Baccarani, M; Bandini, G; Bonifazi, F; Giannini, B; Paolini, S; Ricci, P; Stanzani, M; Vianelli, N | 1 |
| Corcoran, G; Graybill, JR; Hachem, RY; Hare, R; Herbrecht, R; Kontoyiannis, DP; Raad, II | 1 |
| Antin, JH; Baden, LR; Campbell, BJ; Cutler, CS; Fiumara, K; Lowry, CM; Marty, FM | 1 |
| Crum-Cianflone, N; Dull, M; Teneza-Mora, N | 1 |
| Amorosa, V; Bridges, CR; Isidro, AM; Pentz, WH; Rutenberg, HL; Stopyra, GA | 1 |
| Afif, C; Bustamante, AB; Cornely, OA; Gaona-Flores, V; Graham, DR; Graybill, JR; Greenberg, RN; Hadley, S; Langston, A; Negroni, R; Pedicone, L; Perfect, JR; Pitisuttithum, P; Raad, II; Restrepo, A; Schiller, G; Ullmann, AJ | 1 |
| Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F | 1 |
| Gilgado, F; Guarro, J; Mariné, M; Pastor, FJ; Serena, C | 1 |
| Craven, DE; Gorman, SR; Magiorakos, AP; Zimmerman, SK | 1 |
| Derendorf, H; Ihle, F; Theuretzbacher, U | 1 |
| Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A | 1 |
| Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G | 1 |
| Björkholm, M; Cherif, H; Kalin, M | 1 |
| Colpaert, C; De Decker, K; Ieven, M; Jorens, PG; Van Poucke, S; Vogelaers, D; Wojciechowski, M | 1 |
| Kauffman, CA | 1 |
| Rokicka, M | 1 |
| Arndt, M; Cornely, OA; Müller, C; Queckenberg, C; Theisohn, M | 1 |
| Cornely, OA; Karthaus, M | 1 |
| Behringer, K; Cornely, OA; Krüger, K; Kurzai, O; Töx, U; Vehreschild, JJ; Wickenhauser, C | 1 |
| Chusid, MJ; Destino, L; Havens, PL; Helon, AL; Sutton, DA; Thometz, JG; Willoughby, RE | 1 |
| Aperis, G; Mylonakis, E; Spanakis, EK | 1 |
| Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T | 1 |
| Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S | 1 |
| Beck, R; Kaben, U; Tintelnot, K | 1 |
| Proia, LA; Trenholme, GM | 1 |
| Gopal, L; Sen, P; Sen, PR | 1 |
| Burhenne, J; Haefeli, WE; Kaufmann, C; Thiel, MA; Zinkernagel, AS | 1 |
| Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A | 1 |
| Barrao, ME; García-Gil, FA; Jiménez, B; Larraga, J; Luque, P; Serrano, MT; Tomé-Zelaya, E | 1 |
| Galluzzo, ML; Holland, SM; Piontelli, E; Rosenzweig, SD; Santos, PE; Shea, YR; Zelazko, ME | 1 |
| Boggild, AK; Mohan, S; Ostrowski, MA; Poutanen, SM | 1 |
| Belousov, DIu; Veselov, AV | 1 |
| Ayres, BD; Bunya, VY; Cohen, EJ; Hammersmith, KM; Rapuano, CJ | 1 |
| Kantesaria, B; Krishna, G; Martinho, M; Pedicone, L; Sansone-Parsons, A | 1 |
| Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L | 1 |
| Boparai, N; Chandrasekar, P; Durrant, S; Greinix, H; Langston, A; Lipton, JH; Morais de Azevedo, W; Patino, H; Pedicone, L; Reddy, V; Tarantolo, SR; Ullmann, AJ; Vesole, DH | 1 |
| Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ | 1 |
| De Pauw, BE; Donnelly, JP | 1 |
| Beatty, RF; Edward, D; Levy, J; McCartney, DL; Springer, KL; Tu, EY | 1 |
| Paugam, A | 1 |
| Boyken, LB; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S | 1 |
| Scott, LJ; Simpson, D | 1 |
| Maesaki, S | 2 |
| Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J | 1 |
| Alvárez-Espejo, T; Cobo, M; Fernández, I; Muñez, E; Muñoz, M; Ramos, A; Toquero, J | 1 |
| Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
| Kalnicky, C; Klein, J; Mullane, K; Rodriguez, T; Stiff, P; Toor, AA | 1 |
| Almyroudis, NG; Ball, D; Bambach, BJ; Battiwalla, M; Gupta, S; Kwon-Chung, J; McCarthy, PL; Paplham, P; Proefrock, AD; Segal, BH; Varma, A | 1 |
| Jhanji, V; Mannan, R; Sharma, N; Titiyal, JS; Vajpayee, RB | 1 |
| Ho, DY; Lee, JD; Montoya, JG; Rosso, F | 1 |
| Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L | 1 |
| Kwon, DS; Mylonakis, E | 1 |
| Bellmann, R; Weiler, S | 1 |
| Petrikkos, G; Skiada, A | 1 |
| van Dissel, JT; van Nieuwkoop, C | 1 |
| Kontoyiannis, DP; Lewis, RE | 1 |
| Krause, DS | 1 |
| Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K | 1 |
| Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D | 1 |
| Barnett, CJ; Beck, JJ; Edwards, SG; Glynn, NC; Hare, MC; Parry, DW; Ray, R | 1 |
| Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J | 1 |
| Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA | 1 |
| Freifeld, A; Iwen, PC; Kalil, A; Lesiak, B; Sutton, DA; Van Schooneveld, T | 1 |
| Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C | 1 |
| Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L | 1 |
| Esmore, DS; Griffiths, AP; Levvey, BJ; Oto, T; Rowland, M; Snell, GI; Williams, TJ | 1 |
| Drees, M; Gupta, M; Hadley, S; Wickes, BL | 1 |
| Cornely, OA; Farowski, F; Vehreschild, JJ | 1 |
| Schlamm, HT; Supparatpinyo, K | 1 |
| Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C | 1 |
| Park, AJ; Tu, EY | 1 |
| Kauffman, CA; Malani, AN | 1 |
| Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M | 1 |
| Arenz, D; Böhme, A; Buchheidt, D; Cornely, OA; Drzisga, I; Frommolt, P; Harnischmacher, U; Heussel, CP; Hummel, M; Mousset, S; Ullmann, AJ; Vehreschild, JJ; Wassmer, G | 1 |
| Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J | 1 |
| Del Palacio, A; Pontón, J; Quindós, G | 1 |
| Cantón, E; Carrillo-Muñoz, AJ; Eraso, E; Pemán, J; Quindós, G | 1 |
| Alvarez Lerma, F | 1 |
| Jarque, I; Sanz, MA | 1 |
| Salavert, M; Solé, A | 1 |
| Guarro, J; Pastor, FJ | 1 |
| Beckius, ML; Borra, H; Griffith, ME; Hawley, JS; Hospenthal, DR; McCall, S; Moon, JE; Murray, CK; Ressner, RA; Rivard, RG | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| Almirante, B; Rodríguez, D | 1 |
| Hsueh, PR; Huang, LM; Shao, PL | 1 |
| Chodakewitz, JA; Sable, CA; Strohmaier, KM | 1 |
| Anten, S; Heddema, ER; Visser, O; Zweegman, AS | 1 |
| Fung, HB; Schiller, DS | 1 |
| Chandrasekar, P; Krishna, G; Martinho, M; Patino, H; Ullmann, AJ | 1 |
| Dunand, J; Paugam, A | 1 |
| Denning, DW; Pasqualotto, AC | 1 |
| Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM | 1 |
| Erwin, GE; Fitzgerald, JE | 1 |
| Buadi, FK; McClune, B; Przepiorka, D | 1 |
| Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A | 1 |
| Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE | 1 |
| Deresinski, S; Nagappan, V | 1 |
| Fozza, C; La Nasa, G; Longinotti, M; Nieddu, R; Paglietti, B; Podda, L; Sanna, S; Vacca, A | 1 |
| Hogan, H; Howell, A; Lewis, R; Safdar, A | 1 |
| Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M | 1 |
| Nailor, MD; Revankar, SG; Sobel, JD | 1 |
| Boot, B; Danho, C; Huynh, A; Mejdoubi, M | 1 |
| Conlon, JD; Dauenhauer, M; Drolet, BA; Fairley, JA; Margolis, D; Talano, J; Tonkovic-Capin, V | 1 |
| Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ | 1 |
| Almyroudis, NG; Gonzalez, AV; Segal, BH; Ullmann, AJ | 1 |
| Anaissie, E; Buvé, K; Maertens, J | 1 |
| Ali, S; Whittle, AM | 1 |
| Bahari, IS; Deris, ZZ; Harun, A; Ravichandran, M; Roziawati, Y; Shareef, BT | 1 |
| Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL | 1 |
| Bou, G; Fernández, A; Lueiro, F; Velasco, D | 1 |
| Bennett, JE; Zonios, DI | 1 |
| Andes, D; Smith, J | 1 |
| Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
| Barale, PO; Chaumeil, C; Errera, MH; Guez, A; Nourry, H; Sahel, JA; Warnet, JM; Zamfir, O | 1 |
| Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M | 1 |
| Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J | 1 |
| Guarro, J; Mariné, M; Ruíz-Cendoya, M | 1 |
| Polak, A | 2 |
| Plempel, M | 1 |
| Arai, T | 1 |
| Del Palacio-Hernanz, A; Rodriquez-Noriega, A; Sanz-Sanz, F | 1 |
| Ehninger, G; Mölle, M; Schuler, U | 1 |
| Anaissie, EJ; Uzun, O | 1 |
| Anaissie, EJ; Dignani, MC; Hachem, R; Karyotakis, NC | 1 |
| Anaissie, EJ; Dignani, MC; Gokaslan, A; Hachem, R; Karyotakis, NC; Stephens, LC; Tin-U, CK | 1 |
| Björkholm, M | 1 |
| Anaissie, EJ; Andersson, BS; Bodey, GP; Champlin, RE; Giralt, SA; Kantarjian, HM; Karl, C; Kontoyiannis, DP; O'Brien, S; Vartivarian, S | 1 |
| Mochizuki, H; Murakami, K; Ohashi, M; Tsuda, T; Watanabe, T; Yamada, H | 1 |
| Chanock, SJ; Walsh, TJ | 1 |
| Martínez-Suárez, JV; Rodríguez-Tudela, JL | 1 |
| Johnson, EM; Radford, SA; Warnock, DW | 1 |
| Carver, PL; Kauffman, CA | 1 |
| Bouza, E; Muñoz, P | 1 |
| Aristizabal, BH; Stevens, DA | 1 |
| Groll, AH; Piscitelli, SC; Walsh, TJ | 1 |
| Espinel-Ingroff, A | 2 |
| Andriole, VT | 1 |
| Baquero, F | 1 |
| Anaissie, E; Caillot, D; de Marie, S; Graybill, JR; Viviani, MA; Yamaguchi, H | 1 |
| Anaissie, EJ; Arikan, S; Loebenberg, D; Lozano-Chiu, M; Paetznick, VL; Rex, JH | 1 |
| Johnson, EM; Szekely, A; Warnock, DW | 1 |
| Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 1 |
| de Pauw, BE; Kullberg, BJ | 1 |
| Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH | 1 |
| Al-Abdely, HM; Bocanegra, R; Fothergill, A; Graybill, JR; Loebenberg, D; Najvar, L; Rinaldi, MG | 1 |
| Chiou, CC; Groll, AH; Walsh, TJ | 1 |
| Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB | 1 |
| McDougal, EC; Nesky, MA; Peacock, JE | 1 |
| Helwick, C | 1 |
| Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O | 1 |
| Ernst, EJ; Hoffman, HL; Klepser, ME | 1 |
| Arathoon, E; Chiou, C; Ghannoum, M; Groll, AH; Odds, FC; Viviani, MA; Walsh, TJ | 1 |
| Uchida, K; Yamaguchi, H; Yokota, N | 1 |
| Gigliotti, F; Wellington, M | 1 |
| Fukuoka, T; Harasaki, T; Kamai, Y; Kuwahara, S; Ohya, S; Uchida, K; Yamaguchi, H | 1 |
| Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S | 1 |
| Marr, KA | 1 |
| Dixon, CA; Goldberger, MJ; Powers, JH | 1 |
| Hoffman, HL; Rathbun, RC | 1 |
| Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
| Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S | 1 |
| Fothergill, AW; Graybill, JR; McCarthy, DI; Rinaldi, MG; Sun, QN | 1 |
| Dismukes, WE; Lee, J; Walsh, TJ | 1 |
| Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ | 1 |
| Johnson, JR | 1 |
| Cornely, OA; Heussel, CP; Ullmann, AJ | 1 |
| Ghannoum, MA; Kuhn, DM | 1 |
| Arikan, S; Rex, JH | 1 |
| Anaissie, E; Bodey, G; Gokaslan, A; Griffin, G; Hachem, R; Robinson, R; Rubin, R; Sobel, J | 1 |
| Hughes, CE; Terrell, CL | 1 |
| Fujishita, M; Kataoka, R; Kobayashi, M; Miyoshi, I | 1 |
| Graybill, JR; Sharkey, PK | 1 |
| Mahaney, FX | 1 |
| Ackerbauer, H; Meingassner, JG; Mieth, H; Petranyi, G; Schaude, M | 1 |
| Chapman, SW; Cleary, JD; Taylor, JW | 1 |
| Abelin, J; Gip, L | 1 |
| Helenglass, G; Jones, A; Milliken, S; Powles, R | 1 |
| Hino, J; Moriya, O; Nakajima, M; Niki, Y; Soejima, R; Tsukiyama, K; Watanabe, M; Yagi, S | 1 |
| Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S | 1 |
| Arai, S; Iguchi, K; Kamiya, H; Sakurai, M | 1 |
| Goto, H; Goto, M; Mori, H; Nakata, H; Oka, S; Shimada, K; Tokitsu, M | 1 |
| Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O | 1 |
| Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K | 1 |
| Akahonai, Y; Ikemoto, H; Kasai, M; Kawamura, K; Mikuni, C; Mori, T; Taniuchi, A; Watanabe, K; Yoshida, K; Yoshida, T | 1 |
| Dupont, B | 1 |
| Kobayashi, GS; Spitzer, ED | 1 |
| Graybill, JR | 2 |
| Colantino, B; Dietlein, J; Fiscella, R; Peyman, GA; Schulman, JA | 1 |
| Dismukes, WE; Saag, MS | 1 |
| Walsh, TJ | 1 |
| Dismukes, WE | 1 |
| Mattie, H; van Furth, R; Van't Wout, JW | 1 |
| Pizzo, A; Walsh, TJ | 1 |
| van 't Wout, JW; van Furth, R | 1 |
| Meunier, F | 1 |
| Hermans, PE; Terrell, CL | 1 |
226 review(s) available for triazoles and Mycoses
| Article | Year |
|---|---|
The Medicinal Chemistry of 3-nitro-1,2,4-triazoles: Focus on Infectious Diseases.
Topics: Animals; Chagas Disease; Chemistry, Pharmaceutical; Communicable Diseases; Humans; Leishmaniasis; Mycoses; Triazoles; Trypanosomiasis, African; Tuberculosis | 2021 |
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association.
Topics: Adult; Antifungal Agents; Hematology; Humans; Leukemia, Myeloid, Acute; Mycoses; Quality of Life; Triazoles | 2022 |
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole | 2023 |
Prophylaxis of mould infections.
Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Fungal Infections; Mycoses; Triazoles | 2019 |
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.
Topics: Antifungal Agents; Drug Monitoring; Echinocandins; Fluconazole; Humans; Mycoses; Nitriles; Polyenes; Practice Guidelines as Topic; Pyridines; Triazoles | 2020 |
Breakthrough invasive fungal infections: Who is at risk?
Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles | 2020 |
Breakthrough Hormographiella aspergillata Infection in a Patient with Acute Myeloid Leukemia Receiving Posaconazole Prophylaxis: A Case Report and Review.
Topics: Agaricales; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Mycoses; Pneumonia, Necrotizing; Triazoles | 2020 |
Midostaurin in acute myeloid leukemia: current evidence and practical considerations in routine clinical use.
Topics: Aniline Compounds; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Echinocandins; fms-Like Tyrosine Kinase 3; Forecasting; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Maintenance Chemotherapy; Mutation; Mycoses; Protein Kinase Inhibitors; Pyrazines; Randomized Controlled Trials as Topic; Recurrence; Staurosporine; Triazoles | 2020 |
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole | 2020 |
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Mycoses; Nitriles; Phylogeny; Pneumonia; Pyridines; Saccharomycetales; Triazoles | 2021 |
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole | 2021 |
Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
Topics: Adolescent; Adult; Antifungal Agents; Child; Echinocandins; Female; Humans; Leukemia; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Triazoles | 2017 |
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole | 2018 |
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
Topics: Adult; Antifungal Agents; Fungi; Humans; Immunocompromised Host; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Middle Aged; Mucormycosis; Mycoses; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Rare Diseases; Renal Insufficiency; Triazoles | 2018 |
Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis.
Topics: Antifungal Agents; Blood Chemical Analysis; Chemoprevention; Drug Monitoring; Humans; Invasive Fungal Infections; Mycoses; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome; Triazoles | 2018 |
Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review.
Topics: Antifungal Agents; Azoles; Drug Interactions; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Triazoles | 2018 |
Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Drug Design; Drug Discovery; Fluconazole; Fungi; Humans; Models, Molecular; Mycoses; Triazoles | 2019 |
New antifungal antibiotics.
Topics: Antifungal Agents; Echinocandins; Humans; Lung Diseases, Fungal; Mycoses; Triazoles | 2013 |
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Multicenter Studies as Topic; Mycoses; Neutropenia; Odds Ratio; Patient Dropouts; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Treatment Outcome; Triazoles | 2013 |
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature.
Topics: Academic Medical Centers; Administration, Oral; Adult; Age Factors; Aged; Antifungal Agents; Drug Monitoring; Female; Hematologic Diseases; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Mycoses; Prospective Studies; Risk Factors; Triazoles; Young Adult | 2013 |
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2013 |
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole | 2014 |
The role of primary antifungal prophylaxis in patients with haematological malignancies.
Topics: Administration, Intravenous; Antibiotic Prophylaxis; Antifungal Agents; Hematologic Neoplasms; Humans; Meta-Analysis as Topic; Mycoses; Practice Guidelines as Topic; Triazoles | 2014 |
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole | 2014 |
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2014 |
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole | 2014 |
Antifungal pharmacokinetics and pharmacodynamics.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Echinocandins; Flucytosine; Humans; Mice; Mycoses; Polyenes; Rabbits; Rats; Triazoles | 2014 |
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole | 2014 |
Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.
Topics: Antifungal Agents; Humans; Mycoses; Nitriles; Pyridines; Triazoles | 2015 |
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs.
Topics: Antifungal Agents; Chemoprevention; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Mycoses; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Triazoles | 2015 |
Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections.
Topics: Animals; Antifungal Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Gastrointestinal Tract; Humans; Infusions, Intravenous; Mycoses; Tablets, Enteric-Coated; Triazoles | 2015 |
Review of the new delayed-release oral tablet and intravenous dosage forms of posaconazole.
Topics: Administration, Intravenous; Animals; Antifungal Agents; Biological Availability; Delayed-Action Preparations; Humans; Mycoses; Tablets; Triazoles | 2015 |
Pharmacologic and clinical evaluation of posaconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Critical Illness; Delayed-Action Preparations; Humans; Mycoses; Triazoles | 2015 |
The 'cephalosporin era' of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections.
Topics: Animals; Antifungal Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Drug Resistance, Fungal; Fungi; Humans; Immunocompromised Host; Mycoses; Nitriles; Pyridines; Triazoles | 2015 |
[Clinical usefulness of triazole derivatives in the management of fungal infections].
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Fungal; Fungal Proteins; Humans; Kidney Diseases; Mycoses; Squalene Monooxygenase; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2015 |
Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mycoses; Salvage Therapy; Transplant Recipients; Triazoles; United States; United States Food and Drug Administration | 2015 |
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole | 2016 |
Echinocandins: The Expanding Antifungal Armamentarium.
Topics: Animals; Antifungal Agents; Aspergillus; Candida; Candidiasis, Invasive; Drug Therapy, Combination; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2015 |
Dosing of antifungal agents in obese people.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles | 2016 |
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Tolerance; Echinocandins; Flucytosine; Fungi; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2015 |
Triazole antifungals: a review.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Humans; Mycoses; Triazoles | 2015 |
Isavuconazonium sulfate for the treatment of fungal infection.
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Nitriles; Pyridines; Triazoles | 2016 |
Isavuconazonium sulfate (Cresemba)--a new antifungal.
Topics: Antifungal Agents; Aspergillosis; Drug Interactions; Female; Fungi; Humans; Male; Mucormycosis; Mycoses; Nitriles; Pregnancy; Pyridines; Triazoles | 2016 |
Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review.
Topics: Antifungal Agents; Female; Humans; Middle Aged; Mycoses; Paecilomyces; Pneumonia; Triazoles | 2016 |
New facets of antifungal therapy.
Topics: Antifungal Agents; Drug Discovery; Drug Synergism; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Invasive Fungal Infections; Mycoses; Polyenes; Triazoles | 2017 |
Posaconazole: an oral triazole with an extended spectrum of activity.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Risk Factors; Triazoles | 2008 |
Posaconazole for paediatric patients: status of development and future perspectives.
Topics: Adolescent; Adult; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Triazoles | 2008 |
Pramiconazole, a triazole compound for the treatment of fungal infections.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Humans; Imidazoles; Mycoses; Patents as Topic; Triazoles | 2008 |
[Posaconazole: another triazole antifungal of the new generation?].
Topics: Antifungal Agents; Humans; Mycoses; Triazoles | 2008 |
Therapeutic drug monitoring for triazoles.
Topics: Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles | 2008 |
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
Topics: Antifungal Agents; Enterococcus faecium; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycoses; Peritonitis; Postoperative Complications; Tacrolimus; Triazoles; Trichosporon; Vancomycin; Vancomycin Resistance | 2009 |
Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Humans; Infant, Newborn; Mycoses; Triazoles | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Trends in development of new antifungal agents in Japan].
Topics: Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Discovery; Echinocandins; Humans; Japan; Lipopeptides; Mycoses; Triazoles | 2008 |
[Clinical efficacies of antifungal injections].
Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole | 2008 |
Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections.
Topics: Animals; Antifungal Agents; Aspergillus; Candida; Clinical Trials as Topic; Cryptococcus neoformans; Disease Models, Animal; Mycoses; Nitriles; Pyridines; Triazoles | 2008 |
[Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents].
Topics: Amphotericin B; Antibodies, Fungal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Fungal; Candida; Candidiasis; Clinical Trials as Topic; DNA, Fungal; Drug Interactions; Echinocandins; Fungemia; Humans; Mycology; Mycoses; Triazoles; Yeasts | 2008 |
New and investigational triazole agents for the treatment of invasive fungal infections.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Triazoles | 2008 |
Posaconazole: a new oral antifungal agent with an expanded spectrum of activity.
Topics: Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2009 |
Clinical indications for newer antifungal agents.
Topics: Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Drug Therapy; Echinocandins; Endemic Diseases; Humans; Mycoses; Neutropenia; Triazoles; Zygomycosis | 2009 |
Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Drug Dosage Calculations; Drug Interactions; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2009 |
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Humans; Mycoses; Stem Cell Transplantation; Transplantation, Homologous; Triazoles | 2009 |
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole | 2009 |
Fungal postoperative spondylodiscitis due to Scedosporium prolificans.
Topics: Anti-Bacterial Agents; Antifungal Agents; Arthrodesis; Debridement; Discitis; Female; Humans; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Middle Aged; Mycoses; Orthopedic Procedures; Postoperative Complications; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2009 |
Drug-drug interactions of triazole antifungal agents in multimorbid patients and implications for patient care.
Topics: Antifungal Agents; Biotransformation; Comorbidity; Contraindications; Drug Interactions; Food; Gastric Acid; Guidelines as Topic; Humans; Membrane Transport Proteins; Mycoses; Risk Factors; Triazoles | 2009 |
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Topics: Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2009 |
Pharmacology and clinical use of voriconazole.
Topics: Animals; Antifungal Agents; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Primary antifungal prophylaxis in acute myeloblastic leukemia and myelodysplastic syndrome--still an open question?
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Fever; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Medical Oncology; Mycoses; Myelodysplastic Syndromes; Triazoles | 2010 |
Safety of triazole antifungal drugs in patients with cancer.
Topics: Antifungal Agents; Antineoplastic Agents; Drug Interactions; Drug Monitoring; Humans; Mycoses; Neoplasms; Triazoles | 2010 |
Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Quinazolines; Thiazoles; Triazoles | 2010 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
Pharmacokinetic/pharmacodynamic profile of posaconazole.
Topics: Animals; Antifungal Agents; Area Under Curve; Biological Availability; Drug Interactions; Drug Resistance, Fungal; Food-Drug Interactions; Fungi; Humans; Mycoses; Triazoles | 2010 |
[Antifungal therapy for infants, children and adolescents with suspected or documented invasive fungal infection].
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Candidiasis; Child; Child, Preschool; Fever; Humans; Infant; Infant, Newborn; Mycoses; Neoplasms; Neutropenia; Triazoles | 2010 |
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Disease Models, Animal; Fungi; Humans; Mice; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles | 2010 |
Use of posaconazole in the treatment of invasive fungal infections.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Fungi; Graft vs Host Disease; Humans; Immunocompromised Host; Leukemia, Myeloid; Mice; Mycoses; Myelodysplastic Syndromes; Rabbits; Stem Cell Transplantation; Triazoles; United States | 2009 |
Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Risk Factors; Triazoles | 2010 |
Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
New lead structures in antifungal drug discovery.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Carbazoles; Drug Discovery; Echinocandins; Enzyme Inhibitors; Glucosyltransferases; Humans; Mycoses; Naphthoquinones; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2011 |
[Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Mycoses; Triazoles | 2010 |
Pharmacokinetics of antifungal agents in children.
Topics: Adult; Antifungal Agents; Child; Echinocandins; Humans; Immunocompromised Host; Mycoses; Nucleosides; Polyenes; Preventive Medicine; Triazoles | 2011 |
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole | 2010 |
[Recent advances in the study of new antifungal lead compounds].
Topics: Antifungal Agents; Fungi; Heterocyclic Compounds; Humans; Lipopeptides; Molecular Structure; Mycoses; Nitriles; Plant Extracts; Plants, Medicinal; Pyridines; Quinazolines; Quinones; Structure-Activity Relationship; Thiazoles; Triazoles | 2010 |
[Drug interactions in critically-ill patients. An important factor in the use of micafungin?].
Topics: Adult; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Critical Illness; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Infant, Newborn; Lipopeptides; Micafungin; Microsomes, Liver; Mycoses; Triazoles | 2011 |
[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
Topics: Adult; Ambulatory Care; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Male; Meta-Analysis as Topic; Micafungin; Mycoses; Postoperative Complications; Practice Guidelines as Topic; Triazoles | 2011 |
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Antifungal azoles: old and new.
Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Triazoles | 2011 |
[Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Topics: Amphotericin B; Antifungal Agents; Child; Echinocandins; Evidence-Based Medicine; Flucytosine; Humans; Mycoses; Triazoles | 2011 |
New insights into chemistry and anti-infective potential of triazole scaffold.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Models, Molecular; Mycoses; Triazoles; Virus Diseases; Viruses | 2011 |
Posaconazole: a new antifungal weapon.
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Drug Resistance, Fungal; Humans; Immunocompromised Host; Kidney Diseases; Mycoses; Opportunistic Infections; Triazoles | 2011 |
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450.
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Mycoses; Triazoles | 2011 |
Uncommon yeast infections in hematological patients: from diagnosis to treatment.
Topics: Antifungal Agents; Blastomyces; Cryptococcus; Echinocandins; Hematologic Neoplasms; Humans; Mycological Typing Techniques; Mycoses; Survival Rate; Triazoles; Trichosporon | 2011 |
Phototoxicity and photocarcinogenesis associated with voriconazole.
Topics: Antifungal Agents; Biotransformation; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cocarcinogenesis; Comorbidity; Dermatitis, Phototoxic; Drug Interactions; Humans; Immunocompromised Host; Melanoma; Mycoses; Neoplasms, Radiation-Induced; Photochemistry; Postoperative Complications; Pyrimidines; Retinoids; Retrospective Studies; Skin Neoplasms; Sunlight; Transplantation; Triazoles; Voriconazole | 2011 |
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2012 |
Triazole antifungal agents in invasive fungal infections: a comparative review.
Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature.
Topics: Aged; Catheter-Related Infections; DNA, Fungal; Genes, Fungal; Humans; Male; Mycoses; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Scedosporium; Sequence Analysis, DNA; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Invasive mycoses: strategies for effective management.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Aspergillosis; Bilirubin; Biomarkers; Drug Monitoring; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Leukemia; Liver; Liver Function Tests; Male; Middle Aged; Mucormycosis; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Pneumonia; Risk Factors; Triazoles | 2012 |
Therapeutic drug monitoring of voriconazole in children.
Topics: Antifungal Agents; Child; Drug Monitoring; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Posaconazole: the case for therapeutic drug monitoring.
Topics: Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles | 2012 |
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
Topics: Age Factors; Antifungal Agents; Drug Monitoring; Female; Humans; Liver Diseases; Male; Mycoses; Odds Ratio; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Antifungal therapy update: new drugs and medical uses].
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles | 2011 |
Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.
Topics: Animals; Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles | 2012 |
Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.
Topics: Adult; Aged; Antifungal Agents; Bursa, Synovial; Dermatomycoses; Female; Hand; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Synovitis; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature.
Topics: Antifungal Agents; Ascomycota; Granulomatous Disease, Chronic; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Safety and interactions of new antifungals in stem cell transplant recipients.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Interactions; Echinocandins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Opportunistic Infections; Pharmacovigilance; Renal Insufficiency; Stem Cell Transplantation; Triazoles | 2012 |
Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.
Topics: Antifungal Agents; Extracorporeal Membrane Oxygenation; Humans; Infant, Newborn; Mycoses; Triazoles | 2013 |
Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management.
Topics: Antifungal Agents; Granulomatous Disease, Chronic; Humans; Itraconazole; Mycoses; Surgical Procedures, Operative; Triazoles | 2012 |
Making sense of posaconazole therapeutic drug monitoring: a practical approach.
Topics: Antifungal Agents; Drug Monitoring; Humans; Mycoses; Triazoles | 2012 |
Voriconazole in clinical practice.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Safety of posaconazole.
Topics: Animals; Antifungal Agents; Chemistry, Pharmaceutical; Drug Interactions; Histamine H2 Antagonists; Humans; Mycoses; Nausea; Proton Pump Inhibitors; Triazoles | 2013 |
Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
Topics: Aged; Aneurysm, Infected; Antifungal Agents; Aortic Aneurysm; Drug Resistance, Fungal; Female; Humans; Lung Transplantation; Mycoses; Pericarditis; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Endophthalmitis; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2002 |
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.
Topics: Adrenal Cortex Hormones; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Clinical Trials as Topic; Disease Susceptibility; Drug Carriers; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Liposomes; Mycoses; Neutropenia; Recurrence; Risk Factors; Triazoles | 2003 |
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole | 2002 |
Voriconazole: a new triazole antifungal agent.
Topics: Antifungal Agents; Drug Administration Schedule; Drug Interactions; Formularies as Topic; Humans; Length of Stay; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles | 2003 |
[A silver lining on the horizon: new antimycotics].
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Clinical pharmacology of antifungal compounds.
Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Design; Echinocandins; Flucytosine; Fungal Proteins; Humans; Immunocompromised Host; Molecular Structure; Mycoses; Peptides; Peptides, Cyclic; Polyenes; Triazoles | 2003 |
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2002 |
New antifungal drugs and new clinical trials: interpreting results may be difficult.
Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
New antifungal agents.
Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Pharmacokinetics and pharmacodynamics in the development of antifungal compounds.
Topics: Animals; Antifungal Agents; Area Under Curve; Clinical Trials as Topic; Disease Models, Animal; Drug Design; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2003 |
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2004 |
Voriconazole for serious fungal infections.
Topics: Antifungal Agents; Aspergillus; Candida; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
New options for the treatment of invasive fungal infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2004 |
Fungal infections: current diagnosis and treatment.
Topics: Amphotericin B; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Premedication; Randomized Controlled Trials as Topic; Risk Factors; Triazoles | 2004 |
[Voriconazole: a new weapon against invasive fungal infections].
Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Safety; Tissue Distribution; Triazoles; Voriconazole | 2004 |
Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.
Topics: Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Evaluation; Humans; Mycoses; Treatment Outcome; Triazoles | 2004 |
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Voriconazole: therapeutic review of a new azole antifungal.
Topics: Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.
Topics: Adult; Antifungal Agents; Empyema, Subdural; Female; Humans; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2004 |
Management of invasive mycoses in hematology patients: current approaches.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Hematopoietic Stem Cell Transplantation; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides, Cyclic; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles | 2004 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Combination antifungal therapy: where are we now, and where are we going?
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole.
Topics: Antifungal Agents; Ascomycota; Brain Diseases; Central Nervous System Fungal Infections; Humans; Male; Middle Aged; Mycoses; Treatment Outcome; Triazoles | 2005 |
Emerging azole antifungals.
Topics: Animals; Antifungal Agents; Azoles; Drugs, Investigational; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fusarium; Humans; Kidney Transplantation; Middle Aged; Mycoses; Organ Transplantation; Peritonitis; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Update on therapy of invasive mycoses in hematology and oncology].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Voriconazole: review of a broad spectrum triazole antifungal agent.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2005 |
Posaconazole.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Fungi; Humans; Mycoses; Triazoles | 2005 |
Antifungal treatment in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles | 2005 |
Posaconazole: clinical pharmacology and potential for management of fungal infections.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Molecular Structure; Mycoses; Triazoles | 2005 |
Posaconazole.
Topics: Antifungal Agents; Clinical Trials as Topic; Fungi; Humans; Mycoses; Triazoles | 2005 |
Management of systemic fungal infections: alternatives to itraconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles | 2005 |
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole | 2005 |
Posaconazole: a broad-spectrum triazole antifungal.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Treatment Outcome; Triazoles | 2005 |
Voriconazole versus amphotericin B in cancer patients with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole | 2006 |
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Device Removal; Endarterectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leg; Mitosporic Fungi; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2006 |
Pharmacokinetic/pharmacodynamic profile of voriconazole.
Topics: Animals; Antifungal Agents; Biotransformation; Drug Interactions; Fungi; Half-Life; Humans; Mycoses; Protein Binding; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2006 |
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2006 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
Clinical efficacy of new antifungal agents.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Diarrhea; Exanthema; Humans; Mycoses; Nausea; Peptides, Cyclic; Triazoles; Vomiting; Zygomycosis | 2006 |
Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Disease Models, Animal; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Rabbits; Rats; Treatment Outcome; Triazoles | 2006 |
Second-line treatment in invasive mould infections.
Topics: Antifungal Agents; Aspergillosis; Humans; Mycoses; Salvage Therapy; Treatment Outcome; Triazoles; Zygomycosis | 2006 |
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Ascomycota; Biopsy; Fatal Outcome; Histocytochemistry; Humans; Male; Marijuana Abuse; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Voriconazole safety: short review of clinical data].
Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
[The latest data on posaconazole].
Topics: Adult; Animals; Antifungal Agents; Central Nervous System Fungal Infections; Chagas Cardiomyopathy; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mice; Mycoses; Premedication; Triazoles; Trypanocidal Agents | 2007 |
Voriconazole : a review of its use in the management of invasive fungal infections.
Topics: Adolescent; Adult; Antifungal Agents; Child; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
[The future of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2007 |
Aspergillus infection of implantable cardioverter-defibrillators and pacemakers: case report and literature review.
Topics: Aged; Antifungal Agents; Aspergillus flavus; Defibrillators, Implantable; Female; Humans; Mycoses; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole | 2007 |
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Posaconazole: a new broad-spectrum antifungal agent.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Drug Resistance, Fungal; Fungi; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Mycoses; Salvage Therapy; Triazoles | 2007 |
Recent advances in antifungal chemotherapy.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Double-Blind Method; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Multicenter Studies as Topic; Mycoses; Peptides, Cyclic; Randomized Controlled Trials as Topic; Triazoles | 2007 |
Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.
Topics: Antifungal Agents; Humans; International Cooperation; Liver Transplantation; Male; Middle Aged; Mycoses; Paecilomyces; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2008 |
Changing epidemiology of rare mould infections: implications for therapy.
Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis | 2007 |
[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
Topics: Antifungal Agents; Aspergillus; Biofilms; Candida; Cryptococcus; Drug Resistance, Fungal; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
[Role of voriconazole in critically ill patients with invasive mycoses].
Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole | 2007 |
[Current indications for voriconazole in onco-hematological patients].
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis | 2007 |
[Voriconazole for the therapy of mycoses in recipients of solid organ transplants].
Topics: Antibiotic Prophylaxis; Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Mycoses; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole | 2007 |
[The role of voriconazole in the treatment of emerging mycoses].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Antifungal agents in neonates: issues and recommendations.
Topics: Antifungal Agents; Echinocandins; Humans; Infant, Newborn; Mycoses; Polyenes; Pyrimidines; Triazoles | 2007 |
[New development in the treatment of deep-seated mycoses].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Recent advances and challenges in the treatment of invasive fungal infections.
Topics: Antifungal Agents; Aspergillus; Candida; Double-Blind Method; Echinocandins; Fungemia; Fungi; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles | 2007 |
Advances in antifungal therapy.
Topics: Adult; Antifungal Agents; Child; Echinocandins; Humans; Mycoses; Triazoles | 2008 |
Posaconazole: an extended-spectrum triazole antifungal agent.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles | 2007 |
New and emerging treatments for fungal infections.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Quinazolines; Stereoisomerism; Triazoles | 2008 |
Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis; Controlled Clinical Trials as Topic; Disease Models, Animal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2007 |
Use of terbinafine in rare and refractory mycoses.
Topics: Animals; Antifungal Agents; Candida; Dermatomycoses; Drug Resistance, Fungal; Humans; Mycoses; Naphthalenes; Terbinafine; Treatment Outcome; Triazoles | 2008 |
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
Topics: Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Myelodysplastic Syndromes; Neoplasms; Neutropenia; Risk Assessment; Triazoles | 2008 |
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Enzyme-Linked Immunosorbent Assay; Humans; Immunocompromised Host; Mycoses; Neoplasms; Neutropenia; Proteoglycans; Risk Assessment; Tomography, X-Ray Computed; Triazoles | 2008 |
Update on azole antifungals.
Topics: Antifungal Agents; Biological Availability; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Triazoles | 2008 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Antifungal agents--clinical pharmacokinetics and drug interactions.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Future of antifungal and antiviral agents. 1. Antifungal agents].
Topics: Allylamine; Antifungal Agents; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imidazoles; Mycoses; Structure-Activity Relationship; Triazoles | 1984 |
[Prophylaxis and therapy of fungal infections in oncology].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Incidence; Mycoses; Neoplasms; Triazoles | 1995 |
Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Clinical Trials as Topic; Disease Susceptibility; Drug Administration Routes; Hematopoietic Cell Growth Factors; Humans; Immunocompromised Host; Leukocyte Transfusion; Mycoses; Neoplasms; Neutropenia; Triazoles | 1995 |
Chemoprophylaxis of fungal infections in neutropenic patients.
Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Neutropenia; Polyenes; Triazoles | 1994 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
[Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
Topics: Antifungal Agents; Candida albicans; Cell Membrane; DNA Replication; DNA, Fungal; Drug Resistance, Microbial; Drug Resistance, Multiple; Fungi; Imidazoles; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Triazoles | 1996 |
Use of azoles for systemic antifungal therapy.
Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1997 |
[Fungal infections in patients undergoing solid organ transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Celiac Artery; Cytomegalovirus Infections; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Mucormycosis; Mycoses; Postoperative Complications; Risk Factors; Thrombosis; Time Factors; Transplantation; Triazoles | 1997 |
Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.
Topics: Animals; Antifungal Agents; Fungi; Humans; Mycoses; Triazoles | 1998 |
Current and future therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes; Mycoses; Triazoles | 1998 |
New approaches to antifungal chemotherapy.
Topics: Amphotericin B; Animals; Antifungal Agents; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Fungi; Humans; Mycoses; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles | 1998 |
Therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, Combination; Flucytosine; Fungemia; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Mycoses; Neutropenia; Triazoles | 1999 |
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2000 |
Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.
Topics: Antifungal Agents; Brain Abscess; Central Nervous System; Drainage; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole | 2000 |
Novel triazole antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Triazoles | 2000 |
New targets and delivery systems for antifungal therapy.
Topics: Antifungal Agents; Drug Delivery Systems; Drug Design; Fungi; Humans; Mycoses; Triazoles | 2000 |
Update on antifungal agents.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Enzyme Inhibitors; Glucosyltransferases; Humans; Membrane Proteins; Mycoses; Pyrimidines; Schizosaccharomyces pombe Proteins; Treatment Outcome; Triazoles; Voriconazole | 2001 |
Review of the safety and efficacy of voriconazole.
Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole -- better chances for patients with invasive mycoses.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole | 2002 |
Ravuconazole Eisai/Bristol-Myers Squibb.
Topics: Administration, Oral; Animals; Antifungal Agents; Clinical Trials as Topic; Humans; Mycoses; Structure-Activity Relationship; Thiazoles; Triazoles | 2002 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Thromboxane-A Synthase; Triazoles | 1992 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
Imidazoles and triazoles in antifungal therapy.
Topics: Animals; Humans; Imidazoles; Mycoses; Triazoles | 1990 |
Testing of organisms for susceptibility to triazoles: is it justified?
Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1989 |
New antifungal agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Mycoses; Peptides; Peptides, Cyclic; Triazoles | 1989 |
Azole antifungal agents: emphasis on new triazoles.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Triazoles | 1988 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Azole antifungal drugs: old and new.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1988 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
Systemic fungal infections: diagnosis and treatment. I. Therapeutic agents.
Topics: Amphotericin B; Antifungal Agents; Humans; Ketoconazole; Mycoses; Triazoles | 1988 |
67 trial(s) available for triazoles and Mycoses
| Article | Year |
|---|---|
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Topics: Adult; Aged; Antifungal Agents; Humans; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Nitriles; Prospective Studies; Pyridines; Triazoles | 2021 |
A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant.
Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Mycoses; Triazoles; Young Adult | 2021 |
[Efficacy and Safety of Posaconazoleon for Primary Antifungal Prophylaxis against Invasive Fungal Disease in Patients with Stem Cell Transplantation].
Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Mycoses; Stem Cell Transplantation; Triazoles | 2017 |
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Humans; Incidence; Leukemia; Male; Micafungin; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Survival Analysis; Treatment Failure; Triazoles | 2018 |
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole; Wound Healing | 2013 |
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2013 |
Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles | 2013 |
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
Topics: Antifungal Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2013 |
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Laboratory Techniques; Female; Fluconazole; Fungemia; Germany; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles; Young Adult | 2014 |
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2014 |
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluconazole; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; United States | 2014 |
Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.
Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Pharmaceutical Solutions; Triazoles | 2014 |
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Echinocandins; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Triazoles | 2014 |
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Data Collection; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Treatment Outcome; Triazoles; Young Adult | 2014 |
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia.
Topics: Antifungal Agents; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Tablets; Triazoles | 2014 |
Safety and pharmacokinetics of isavuconazole as antifungal prophylaxis in acute myeloid leukemia patients with neutropenia: results of a phase 2, dose escalation study.
Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunosuppression Therapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Nitriles; Patient Safety; Pyridines; Triazoles | 2015 |
Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prospective Studies; Salvage Therapy; Triazoles | 2015 |
Determination of posaconazole concentration with LC-MS/MS in adult patients with hematologic malignancy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chromatography, Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Tandem Mass Spectrometry; Triazoles; Young Adult | 2015 |
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult | 2016 |
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Female; Histoplasmosis; Humans; Male; Middle Aged; Mycoses; Nitriles; Paracoccidioidomycosis; Pyridines; Triazoles; Young Adult | 2016 |
Posaconazole Tablet Formulation at 400 Milligrams Daily Achieves Desired Minimum Serum Concentrations in Adult Patients with a Hematologic Malignancy or Stem Cell Transplant.
Topics: Adult; Aged; Antifungal Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Treatment Outcome; Triazoles | 2016 |
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Tablets; Triazoles | 2017 |
Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Prospective Studies; Single-Blind Method; Triazoles; Young Adult | 2008 |
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult | 2010 |
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Population; Single-Blind Method; Triazoles; Young Adult | 2010 |
Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients.
Topics: Adolescent; Adult; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Triazoles; Young Adult | 2011 |
Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma.
Topics: Antifungal Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Graft vs Host Disease; Humans; Mycoses; Neutropenia; Stem Cell Transplantation; Treatment Outcome; Triazoles | 2010 |
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
Topics: Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Injections, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Topics: Administration, Topical; Anti-Infective Agents, Local; Antifungal Agents; Cornea; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2010 |
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles | 2010 |
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
Topics: Adult; Aged; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia; Male; Middle Aged; Mycoses; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbiological Techniques; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2011 |
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole | 2012 |
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2011 |
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Area Under Curve; Biological Availability; Diet, High-Fat; Dietary Supplements; Drug Administration Schedule; Drug Dosage Calculations; Female; Gastrointestinal Tract; Humans; Immunocompromised Host; Intestinal Absorption; Male; Middle Aged; Mycoses; Risk; Triazoles | 2012 |
A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Candida; Drug Tolerance; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Salvage Therapy; Triazoles; Young Adult | 2012 |
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
Topics: Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2012 |
Voriconazole for fungal corneal ulcers.
Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.
Topics: Administration, Oral; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Leukemia; Lipids; Lymphoma; Male; Middle Aged; Mycoses; Prospective Studies; Risk; Tacrolimus; Time Factors; Transplantation, Homologous; Triazoles | 2012 |
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
Topics: Aged; Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Triazoles | 2012 |
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole | 2013 |
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2005 |
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.
Topics: Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Female; Fever; Humans; Male; Middle Aged; Mycoses; Neutropenia; Triazoles | 2006 |
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Female; Fusarium; Humans; Leukemia; Male; Middle Aged; Mycoses; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles | 2006 |
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mycoses; Triazoles | 2006 |
Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aqueous Humor; Aspergillus fumigatus; Candida albicans; Humans; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Body Surface Area; Body Weight; Child; Female; Humans; Male; Mycoses; Treatment Outcome; Triazoles | 2007 |
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Opportunistic Infections; Risk Factors; Triazoles | 2007 |
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles | 2007 |
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Placebos; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2007 |
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Chronic Disease; Diarrhea; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Racial Groups; Sex Factors; Transplantation, Homologous; Triazoles | 2007 |
Double-blind investigation of R-42470 (terconazole cream 0.4%) and clotrimazole (cream 1%) for the topical treatment of mycotic vaginitis.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Clotrimazole; Double-Blind Method; Female; Humans; Imidazoles; Middle Aged; Mycoses; Ointments; Pregnancy; Pregnancy Complications, Infectious; Triazoles; Vaginitis | 1984 |
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Female; Humans; Leukemia; Male; Middle Aged; Mycoses; Neoplasms; Opportunistic Infections; Prospective Studies; Triazoles | 1993 |
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2002 |
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2002 |
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2002 |
[Clinical study of fluconazole on deep-seated fungal infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Cryptococcosis; Drug Tolerance; Female; Fluconazole; Humans; Japan; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Triazoles | 1989 |
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Clinical Trials as Topic; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles | 1988 |
610 other study(ies) available for triazoles and Mycoses
| Article | Year |
|---|---|
Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections.
Topics: Adolescent; Antifungal Agents; Humans; Immunocompromised Host; Mycoses; Triazoles | 2022 |
[Efficacy of Posaconazole for Primary Prophylaxis in the Induction Therapy of Childhood Acute Lymphoblastic Leukemia].
Topics: Antifungal Agents; Child; Humans; Induction Chemotherapy; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Prevention; Triazoles | 2021 |
Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Organ Transplantation; Pyridines; Transplant Recipients; Triazoles | 2022 |
Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China.
Topics: Antifungal Agents; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Mycoses; Tablets; Triazoles | 2022 |
Model-Informed Dose Justifications of Posaconazole in Japanese Patients for Prophylaxis and Treatment Against Fungal Infection.
Topics: Administration, Oral; Antifungal Agents; East Asian People; Humans; Mycoses; Tablets; Triazoles | 2023 |
Widespread triazole pesticide use affects infection dynamics of a global amphibian pathogen.
Topics: Amphibians; Animals; Chytridiomycota; Mycoses; Pesticides; Plant Breeding; Triazoles | 2023 |
Population Pharmacokinetics, Exposure-Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep-Seated Mycoses.
Topics: Animals; East Asian People; Humans; Mice; Mycoses; Probability; Triazoles | 2023 |
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Species Specificity; Triazoles | 2019 |
Plasma exposures following posaconazole delayed-release tablets in immunocompromised children and adolescents.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Delayed-Action Preparations; Female; Humans; Immunocompromised Host; Liver; Liver Function Tests; Male; Mycoses; Plasma; Retrospective Studies; Tablets; Triazoles | 2019 |
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
Agricultural systems as potential sources of emerging human mycoses caused by Trichoderma: a successful, common phylotype of Trichoderma longibrachiatum in the frontline.
Topics: Agriculture; Antifungal Agents; Environmental Exposure; Environmental Microbiology; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mycological Typing Techniques; Mycoses; Phylogeny; Triazoles; Trichoderma | 2019 |
Identification and functional characterization of
Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Asia, Southeastern; ATP Binding Cassette Transporter, Subfamily B; Candida albicans; Drug Resistance, Fungal; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Mycoses; Phylogeny; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Talaromyces; Transcriptome; Triazoles | 2020 |
Posaconazole delayed-release tablets in paediatric haematology-oncology patients.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Delayed-Action Preparations; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Retrospective Studies; Tablets; Triazoles | 2020 |
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia.
Topics: Aged; Anidulafungin; Antifungal Agents; Drug Combinations; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney; Leukemia, Myeloid, Acute; Liver; Male; Mycoses; Nitriles; Positron-Emission Tomography; Pyridines; Spleen; Treatment Outcome; Triazoles | 2020 |
Combination antifungal therapy for Scedosporium species in cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Ascomycota; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Mycoses; Retrospective Studies; Scedosporium; Terbinafine; Treatment Outcome; Triazoles | 2020 |
Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Serum; Sex Factors; Triazoles; United Kingdom; Young Adult | 2020 |
Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation.
Topics: Antifungal Agents; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Retrospective Studies; Triazoles | 2020 |
In vitro activity of isavuconazole against clinically isolated yeasts from Chile.
Topics: Antifungal Agents; Chile; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Yeasts | 2020 |
Successful salvage therapy for fungal bronchial anastomotic infection after -lung transplantation with an inhaled triazole anti-fungal PC945.
Topics: Administration, Inhalation; Adult; Anastomosis, Surgical; Bronchi; Bronchitis; Dose-Response Relationship, Drug; Female; Fungi; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Salvage Therapy; Surgical Wound Infection; Triazoles | 2020 |
Case Report: Successful Treatment of Pulmonary Talaromyces marneffei Infection with Posaconazole in a Renal Transplant Recipient.
Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Kidney Transplantation; Lung; Male; Mycoses; Respiratory Tract Infections; Talaromyces; Tomography, X-Ray Computed; Transplant Recipients; Triazoles | 2020 |
Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
Topics: Adolescent; Antifungal Agents; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Tertiary Care Centers; Triazoles | 2021 |
Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Cytochrome P-450 CYP3A; Diarrhea; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Mycoses; Staurosporine; Triazoles | 2021 |
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole | 2021 |
Triazole antifungal use for prophylaxis and treatment of invasive fungal diseases for patients receiving gilteritinib.
Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Antifungal Agents; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Prognosis; Pyrazines; Retrospective Studies; Survival Rate; Triazoles; Young Adult | 2021 |
Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).
Topics: Antifungal Agents; Asia; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pacific Islands; Public Health Surveillance; Triazoles | 2021 |
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole | 2021 |
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole | 2017 |
Isavuconazole: is there a need for a new antifungal?
Topics: Antifungal Agents; Drug Discovery; Humans; Mycoses; Nitriles; Pyridines; Triazoles | 2017 |
Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Central Venous Catheters; Child; Child, Preschool; Consolidation Chemotherapy; Female; Humans; Incidence; Induction Chemotherapy; Infant; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Retrospective Studies; Risk Factors; Serum Albumin; Sex Factors; Triazoles; Young Adult | 2017 |
Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Topics: Adult; Aged; Antifungal Agents; Female; Fluconazole; Galactose; Guideline Adherence; Guidelines as Topic; Humans; Leukemia, Myeloid, Acute; Male; Mannans; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Retrospective Studies; Triazoles | 2017 |
SEIFEM 2010-E: economic evaluation of posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia receiving induction chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Drug Costs; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Monte Carlo Method; Mycoses; Outcome Assessment, Health Care; Triazoles; Young Adult | 2017 |
Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Spain; Tablets; Triazoles | 2018 |
Development of indicators for evaluating the appropriate use of triazoles for invasive fungal disease: A Delphi panel survey.
Topics: Adult; Antifungal Agents; Drug Interactions; Female; Humans; Male; Middle Aged; Mycoses; Pharmacists; Surveys and Questionnaires; Triazoles | 2017 |
[Primary antifungal prophylaxis with posaconazole plays a pivotal role during chemotherapy of acute myeloid leukemia].
Topics: Antifungal Agents; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Mycoses; Remission Induction; Retrospective Studies; Triazoles | 2017 |
Topics: Adult; Antifungal Agents; Ascomycota; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Imidazoles; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Triazoles; Yeasts; Young Adult | 2017 |
Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult | 2018 |
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Topics: Administration, Topical; Adult; Antifungal Agents; Cystic Fibrosis; Emphysema; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Salvage Therapy; Scedosporium; Transplant Recipients; Triazoles | 2018 |
Necrotizing Microascus tracheobronchitis in a bilateral lung transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bronchi; Bronchitis; Endoscopy; Female; Humans; Immunocompromised Host; Lung Transplantation; Middle Aged; Mycoses; Necrosis; Transplant Recipients; Treatment Outcome; Triazoles | 2018 |
Novel approaches to antifungal therapy.
Topics: Humans; Mycoses; Salvage Therapy; Scedosporium; Transplant Recipients; Triazoles | 2018 |
Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia.
Topics: Abdominal Pain; Adolescent; Constipation; Female; Humans; Hypertension; Muscle Weakness; Mycoses; Neuralgia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles; Vincristine | 2018 |
Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.
Topics: Administration, Oral; Adolescent; Anemia, Aplastic; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mycoses; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Triazoles | 2018 |
Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Mycoses; Nitriles; Prodrugs; Pyridines; Scedosporium; Triazoles | 2018 |
Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Scedosporium; Triazoles | 2019 |
Treatment of Suspected Invasive Fungal Infection in War Wounds.
Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries | 2018 |
Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leukemia; Liver Function Tests; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Retrospective Studies; Triazoles; Young Adult | 2019 |
Posaconazole Administration in Hospitalized Children in the United States.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Prescriptions; Female; Hospitalization; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Mycoses; Retrospective Studies; Triazoles; United States | 2019 |
Managing liver dysfunction in haematology patients: Switch antifungals, or use the tincture of time?
Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Drug Substitution; Female; Humans; Leukemia, Myeloid, Acute; Liver Diseases; Liver Function Tests; Male; Middle Aged; Mycoses; Retrospective Studies; Time Factors; Triazoles; Young Adult | 2019 |
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole | 2019 |
A case of Verruconis gallopava infection in a heart transplant recipient successfully treated with posaconazole.
Topics: Antifungal Agents; Ascomycota; Heart Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Thorax; Tomography, X-Ray Computed; Treatment Outcome; Triazoles | 2019 |
Posaconazole trough concentrations are not influenced by inflammation: A prospective study.
Topics: Adult; Aged; Antifungal Agents; C-Reactive Protein; Female; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Triazoles; Young Adult | 2019 |
Real-world use-Isavuconazole at a large academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Retrospective Studies; Survival Analysis; Treatment Outcome; Triazoles; United States | 2019 |
Posaconazole salvage therapy: The Posifi study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood Chemical Analysis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Salvage Therapy; Spain; Tertiary Care Centers; Treatment Outcome; Triazoles; Withholding Treatment | 2019 |
Why do lung transplant patients discontinue triazole prophylaxis?
Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole | 2019 |
Screening the in vitro susceptibility of posaconazole in clinical isolates of Candida spp. and Aspergillus spp. and analyzing the sequence of ERG11 or CYP51A in non-wild-type isolates from China.
Topics: Antifungal Agents; Aspergillus; Candida; China; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Mycoses; Triazoles | 2019 |
Voriconazole is cytotoxic at locally delivered concentrations: a pilot study.
Topics: Animals; Antifungal Agents; Cell Line; Cell Proliferation; Cell Survival; Fibroblasts; Mice; Mycoses; Osteoblasts; Pilot Projects; Pyrimidines; Triazoles; Voriconazole | 2013 |
Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: a cost-effectiveness analysis in Greece.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Greece; Health Expenditures; Humans; Immunocompromised Host; Itraconazole; Models, Economic; Mycoses; Neutropenia; Triazoles | 2013 |
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole | 2013 |
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Nystatin; Opportunistic Infections; Saccharomyces cerevisiae; Species Specificity; Terbinafine; Triazoles | 2012 |
Preemptive treatment with voriconazole in lung transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus fumigatus; Cohort Studies; Female; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Outcome of allogeneic SCT in patients with pre-transplant invasive fungal infection.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Mycoses; Triazoles | 2013 |
Disseminated Ochroconis gallopava infection in a heart transplant patient.
Topics: Antifungal Agents; Ascomycota; Brain; Fatal Outcome; Heart Transplantation; Humans; Lung; Male; Middle Aged; Mycoses; Peritoneum; Pyrimidines; Triazoles; Voriconazole | 2013 |
Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis.
Topics: Antifungal Agents; Compassionate Use Trials; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2013 |
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
No effect of antifungal compounds on functional properties of human antifungal T-helper type 1 cells.
Topics: Antifungal Agents; Cells, Cultured; Hematopoietic Stem Cell Transplantation; Humans; Interferon-gamma; Lymphocyte Activation; Mycoses; Th1 Cells; Triazoles; Tumor Necrosis Factor-alpha | 2013 |
What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?
Topics: Antifungal Agents; Drug Monitoring; Female; Fungi; Humans; Male; Mycoses; Triazoles | 2013 |
Reply to "What types of Candida infections should be included when evaluating breakthrough infections during posaconazole prophylaxis?".
Topics: Antifungal Agents; Drug Monitoring; Female; Fungi; Humans; Male; Mycoses; Triazoles | 2013 |
Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult | 2013 |
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic
Topics: Antifungal Agents; Echinocandins; Fungi; Global Health; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles; Yeasts | 2013 |
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2013 |
Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
Topics: Adolescent; Aged; Aged, 80 and over; Antifungal Agents; Child; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Liver; Liver Function Tests; Logistic Models; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis.
Topics: Adolescent; Adult; Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Economics, Pharmaceutical; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Remission Induction; Retrospective Studies; Triazoles; Young Adult | 2014 |
Isavuconazole activity against Aspergillus lentulus, Neosartorya udagawae, and Cryptococcus gattii, emerging fungal pathogens with reduced azole susceptibility.
Topics: Antifungal Agents; Aspergillus; Azoles; Communicable Diseases, Emerging; Cryptococcus gattii; Humans; Microbial Sensitivity Tests; Mycoses; Neosartorya; Nitriles; North America; Pyridines; Triazoles | 2013 |
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
Topics: Adult; Antifungal Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2013 |
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole | 2013 |
Posaconazole concentrations after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult | 2013 |
Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Middle Aged; Mucormycosis; Mycoses; Triazoles; Young Adult | 2013 |
Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Aspergillus fumigatus; Biological Transport; Cell Line; Cell Membrane; Epithelial Cells; Fungi; Humans; Mycoses; Protein Binding; Spores, Fungal; Triazoles | 2013 |
Posaconazole treatment in Korea: single-center experience over 5 years.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Mycoses; Republic of Korea; Salvage Therapy; Triazoles | 2013 |
Subacute exogenous Rhizoctonia solani endophthalmitis following cataract extraction with intraocular lens implantation.
Topics: Acute Disease; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Rhizoctonia; Triazoles; Vitrectomy; Voriconazole | 2013 |
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2014 |
Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Catheter-Related Infections; Chemotherapy-Induced Febrile Neutropenia; Clinical Trials as Topic; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Echinocandins; Fungemia; Humans; Immunocompromised Host; Immunotherapy; Invasive Pulmonary Aspergillosis; Mycoses; Neoplasms; Salvage Therapy; Triazoles | 2014 |
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient.
Topics: Antifungal Agents; Brain Abscess; Cerebral Phaeohyphomycosis; Coinfection; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations.
Topics: Adult; Aged; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Proton Pump Inhibitors; Retrospective Studies; Triazoles | 2013 |
Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult | 2014 |
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2013 |
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2014 |
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms | 2014 |
Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia; Male; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Access to a new class of biologically active quinoline based 1,2,4-triazoles.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Quinolines; Structure-Activity Relationship; Triazoles | 2014 |
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole | 2014 |
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.
Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Turkey; Voriconazole | 2013 |
Synthesis and biological evaluation of α-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albumin.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Cattle; Chalcones; DNA; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Serum Albumin; Triazoles | 2014 |
Is there still a place for itraconazole prophylaxis in high-risk hematology patients?
Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Mycoses; Triazoles | 2014 |
Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2014 |
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult | 2014 |
Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench story.
Topics: Antifungal Agents; Chemoprevention; Hematologic Diseases; Humans; Mycoses; Triazoles | 2014 |
Microwave assistant synthesis, antifungal activity and DFT theoretical study of some novel 1,2,4-triazole derivatives containing pyridine moiety.
Topics: Antifungal Agents; Chemistry Techniques, Synthetic; Fungi; Humans; Microwaves; Models, Molecular; Mycoses; Pyridines; Triazoles | 2014 |
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles | 2014 |
Tumorlike cardiac fungal mycetoma caused by Scedosporium apiospermum presenting as symptomatic ventricular tachycardia.
Topics: Adult; Antifungal Agents; Heart; Hemodynamics; Humans; Male; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Tachycardia, Ventricular; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Alopecia and nail changes associated with voriconazole therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole | 2014 |
Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole.
Topics: Administration, Oral; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Triazoles | 2014 |
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Female; France; Humans; Immunocompromised Host; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult | 2014 |
Posaconazole concentrations in human tissues after allogeneic stem cell transplantation.
Topics: Antifungal Agents; Autopsy; Brain Chemistry; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney; Liver; Lung; Mycoses; Myocardium; Transplantation, Homologous; Triazoles | 2014 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
Experimental treatment of Curvularia infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Malassezia pachydermatis fungaemia in an adult on posaconazole prophylaxis for acute myeloid leukaemia.
Topics: Aged; Antifungal Agents; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Malassezia; Male; Mycoses; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Superinfection; Triazoles | 2014 |
Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
Topics: Animals; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycoses; Random Allocation; Scedosporium; Triazoles | 2014 |
Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Treatment Outcome; Triazoles; Withholding Treatment; Young Adult | 2014 |
Review: voriconazole for prevention or treatment of invasive fungal infections in cancer with neutropenia.
Topics: Amphotericin B; Antifungal Agents; Humans; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles | 2014 |
Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Mycoses; Retrospective Studies; Survival Rate; Triazoles | 2014 |
Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Austria; Chemoprevention; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Medication Adherence; Middle Aged; Mycoses; Patient Education as Topic; Plasma; Triazoles; Young Adult | 2014 |
Posaconazole salvage treatment for invasive fungal infection.
Topics: Adult; Aged; Antifungal Agents; Byssochlamys; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mucor; Mycoses; Retrospective Studies; Salvage Therapy; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Withholding Treatment | 2014 |
Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.
Topics: Antifungal Agents; Echinocandins; Fungi; Global Health; Hospitals; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2014 |
Synthesis of antifungal evaluation of 2H-[1,2,3]Triazolo[4,5-g]isoquinoline-4,9-diones.
Topics: Antifungal Agents; Drug Design; Fungi; Humans; Isoquinolines; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Triazoles | 2014 |
Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Female; Food-Drug Interactions; Gastrointestinal Absorption; Humans; Leukemia; Liver; Male; Middle Aged; Mycoses; Suspensions; Tablets; Triazoles | 2014 |
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult | 2015 |
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; China; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mycoses; Risk Factors; Triazoles | 2015 |
Keratitis by Fusarium temperatum, a novel opportunist.
Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; Echinocandins; Fungal Proteins; Fusarium; Humans; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Mycoses; Phylogeny; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Tubulin; Zea mays | 2014 |
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Retrospective Studies; Taiwan; Treatment Outcome; Triazoles; Young Adult | 2016 |
An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States.
Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid; Mycoses; Triazoles; United States | 2015 |
Synthesis, spectroscopic, thermal and antimicrobial studies of neodymium(III) and samarium(III) complexes derived from tetradentate ligands containing N and S donor atoms.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coordination Complexes; Fungi; Humans; Ligands; Microbial Sensitivity Tests; Mycoses; Neodymium; Samarium; Schiff Bases; Spectrum Analysis; Temperature; Triazoles | 2015 |
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Incidence; Infant; Itraconazole; Male; Mycoses; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Triazoles | 2015 |
Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Randomized Controlled Trials as Topic; Retrospective Studies; Suspensions; Triazoles; Young Adult | 2015 |
Isavuconazonium sulfate approved for invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Drug Approval; Humans; Infusions, Intravenous; Mycoses; Nitriles; Prodrugs; Pyridines; Triazoles | 2015 |
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Topics: Adolescent; Adult; Antifungal Agents; China; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Mycoses; Myeloablative Agonists; Neutropenia; Prognosis; Prospective Studies; Risk Factors; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Triazoles; Unrelated Donors | 2015 |
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole | 2015 |
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Fluconazole; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Remission Induction; Retrospective Studies; Survival Analysis; Triazoles | 2016 |
Suspected posaconazole toxicity in a pediatric oncology patient.
Topics: Adolescent; Anorexia; Antifungal Agents; Combined Modality Therapy; Delayed-Action Preparations; Drug Therapy, Combination; Fatigue; Female; Humans; Hypokalemia; Maxillary Sinus Neoplasms; Medication Errors; Musculoskeletal Pain; Mycoses; Osteosarcoma; Postoperative Complications; Sinusitis; Triazoles | 2015 |
Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and prop
Topics: Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Global Health; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles | 2015 |
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Suspensions; Tablets; Triazoles; Young Adult | 2015 |
Isavuconazole: a new extended spectrum triazole for invasive mold diseases.
Topics: Antifungal Agents; Double-Blind Method; Fungi; Humans; Mycoses; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles | 2015 |
In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.
Topics: Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Scopulariopsis; Terbinafine; Triazoles | 2015 |
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Biological Availability; Body Mass Index; Body Weight; Delayed-Action Preparations; Diarrhea; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Triazoles; Young Adult | 2015 |
Paradoxical response preceding control of Scedosporium apiospermum mycetoma with posaconazole treatment.
Topics: Adult; Antifungal Agents; Contraindications; Humans; Immunocompromised Host; Male; Mycetoma; Mycoses; Scedosporium; Triazoles | 2015 |
Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles | 2015 |
Reply to Wong et al.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Mycoses; Triazoles | 2015 |
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Cost Savings; Cost-Benefit Analysis; Drug Costs; Female; Fluconazole; Hospital Costs; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Primary Prevention; Propensity Score; Remission Induction; Republic of Korea; Retrospective Studies; Triazoles | 2015 |
Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Incidence; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Remission Induction; Republic of Korea; Retrospective Studies; Time Factors; Triazoles | 2015 |
Treatment trial of clinically ill corroboree frogs with chytridiomycosis with two triazole antifungals and electrolyte therapy.
Topics: Animals; Antifungal Agents; Anura; Chytridiomycota; Electrolytes; Mycoses; Random Allocation; Survival Analysis; Treatment Outcome; Triazoles | 2015 |
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult | 2015 |
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles | 2016 |
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2015 |
Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.
Topics: Animals; Antifungal Agents; Basidiomycota; beta-Glucans; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Immunocompromised Host; Kidney; Male; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Neutropenia; Proteoglycans; Triazoles | 2015 |
Synthesis and Antimicrobial Evaluation of Thieno[2,3-d]-pyrimidine, Thieno[2',3':4,5]pyrimido[1,2-a][1,3,5]triazine, Thieno[2,3-d]-1,3-thiazine and 1,2,4-Triazole Systems.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Isothiocyanates; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Thiazines; Triazines; Triazoles | 2015 |
Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Diet; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Plasma; Transplantation, Homologous; Triazoles | 2016 |
Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Body Surface Area; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Plasma; Prospective Studies; Suspensions; Triazoles | 2016 |
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Monitoring; Female; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles | 2015 |
Isavuconazole: a role for the newest broad-spectrum triazole.
Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2016 |
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Interactions; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycoses; Tacrolimus; Triazoles; Young Adult | 2016 |
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole | 2016 |
Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Young Adult | 2016 |
Azide-enolate 1,3-dipolar cycloaddition in the synthesis of novel triazole-based miconazole analogues as promising antifungal agents.
Topics: Antifungal Agents; Aspergillus fumigatus; Azides; Candida; Cycloaddition Reaction; Fungi; Humans; Miconazole; Microbial Sensitivity Tests; Mycoses; Rhizopus; Triazoles | 2016 |
Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antifungal Agents; beta-Cyclodextrins; Drug Carriers; Fungi; Humans; Models, Molecular; Mycoses; Solubility; Triazoles; Water | 2016 |
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2015 |
1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Quinazolines; Tetrahydrofolate Dehydrogenase; Triazoles | 2016 |
Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.
Topics: Administration, Oral; Adult; Antifungal Agents; Citrulline; Female; Hematopoietic Stem Cell Transplantation; Humans; Intestinal Mucosa; Male; Middle Aged; Mucositis; Mycoses; Suspensions; Tablets; Triazoles | 2016 |
Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: Trough serum concentrations in relation to outcome.
Topics: Adult; Aged; Chemoprevention; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Serum; Treatment Outcome; Triazoles; Young Adult | 2016 |
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy.
Topics: Administration, Oral; Adult; Antifungal Agents; Chemoprevention; Chromatography, Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Tandem Mass Spectrometry; Triazoles | 2016 |
Fungal infection of cystic fibrosis patients - single center experience.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts | 2016 |
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; ROC Curve; Triazoles | 2016 |
Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
Topics: Administration, Intravenous; Adult; Antifungal Agents; Australia; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Plasma; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Triazoles | 2016 |
Posaconazole Therapeutic Drug Monitoring in a Regional Hospital Setting.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Monitoring; Female; Hospitals; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Serum; Triazoles; Young Adult | 2016 |
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.
Topics: Adolescent; Age Factors; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neutropenia; Plasma; Retrospective Studies; Sex Factors; Triazoles | 2017 |
Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fungi; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Triazoles | 2017 |
Acute reversible pancreatitis induced by posaconazole.
Topics: Acute Disease; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Lipase; Mycoses; Pancreatitis; Triazoles | 2017 |
Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.
Topics: Administration, Oral; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Humans; Male; Mycoses; Retrospective Studies; Suspensions; Triazoles | 2017 |
Hypokalemia and Hypertension Associated with Supratherapeutic Posaconazole Levels.
Topics: Adult; Antifungal Agents; Histoplasmosis; Humans; Hypertension; Hypokalemia; Lymphoma, Large B-Cell, Diffuse; Male; Mycoses; Triazoles | 2017 |
Diaporthe soft tissue infection in a heart transplant patient.
Topics: Aged; Antifungal Agents; Ascomycota; DNA, Fungal; Glycopeptides; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Mycoses; Myocardial Ischemia; Polymerase Chain Reaction; Soft Tissue Infections; Thigh; Tomography, X-Ray Computed; Triazoles | 2017 |
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole | 2008 |
[Use of topical voriconazole in Alternaria keratitis].
Topics: Administration, Oral; Adult; Alternaria; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Humans; Keratitis; Keratoplasty, Penetrating; Male; Mycoses; Ophthalmic Solutions; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Europe; Fungi; Guidelines as Topic; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles; Yeasts | 2008 |
Breakpoints for posaconazole susceptibility testing: background and discussion about the need of establishing values.
Topics: Antifungal Agents; Drug Resistance, Fungal; Endpoint Determination; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2008 |
Posaconazole in intensive care patients I: invasive fungal infections in surgical intensive care and case presentation.
Topics: Aged; Antifungal Agents; Aspergillosis; Candidiasis; Critical Care; Cross Infection; Humans; Middle Aged; Mycoses; Postoperative Complications; Triazoles | 2008 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles | 2008 |
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2008 |
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycoses; Organ Transplantation; Postoperative Complications; Retrospective Studies; Safety; Treatment Outcome; Triazoles | 2008 |
Alternaria infectoria brain abscess in a child with chronic granulomatous disease.
Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole | 2009 |
Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
Topics: Antifungal Agents; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
Topics: Adolescent; Antifungal Agents; Antigens, Fungal; Bone Marrow Transplantation; DNA, Fungal; Graft vs Host Disease; Humans; Immunocompromised Host; Latex Fixation Tests; Male; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2008 |
Studies with new fungistatic agents for the treatment of superficial mycoses.
Topics: Dermatomycoses; Mycoses; Triazoles | 1948 |
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Topics: Africa; Antifungal Agents; Asia, Southeastern; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Latin America; Microbial Sensitivity Tests; Middle East; Mycoses; North America; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2009 |
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Child; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2009 |
Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Drug Therapy, Combination; Humans; Male; Mycoses; Naphthalenes; Paecilomyces; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia.
Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Monte Carlo Method; Multicenter Studies as Topic; Mycoses; Neutropenia; Triazoles | 2008 |
Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Spleen; Triazoles | 2009 |
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis | 2008 |
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles | 2009 |
In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles | 2009 |
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2008 |
The use of voriconazole in the treatment of cylindrocarpon keratomycosis.
Topics: Antifungal Agents; Ascomycota; Cornea; Corneal Ulcer; Drug Resistance, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Scedosporium apiospermum skeletal infection in an immunocompetent child.
Topics: Antifungal Agents; Child; Female; Humans; Knee; Mycoses; Osteomyelitis; Pyrimidines; Radiography; Scedosporium; Triazoles; Voriconazole | 2009 |
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2009 |
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach.
Topics: Antifungal Agents; Child; Debridement; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Infusions, Parenteral; Mycoses; Polyenes; Polyvinyl Chloride; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2008 |
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole | 2009 |
Posaconazole therapeutic drug monitoring: a reference laboratory experience.
Topics: Antifungal Agents; Chemoprevention; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Laboratories; Mycoses; Reference Standards; Texas; Triazoles | 2009 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries | 2009 |
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Posaconazole-increased vincristine neurotoxicity in a child: a case report.
Topics: Antifungal Agents; Antineoplastic Agents, Phytogenic; Child; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Mycoses; Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Triazoles; Vincristine | 2009 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
Evaluating the resistance to posaconazole by E-test and CLSI broth microdilution methodologies of Candida spp. and pathogenic moulds.
Topics: Antifungal Agents; Candida; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2009 |
Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole.
Topics: Antifungal Agents; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycoses; Neosartorya; Peritoneal Dialysis; Peritonitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles | 2009 |
Posaconazole: new indications. Prevention of invasive mycosis and treatment of oropharyngeal candidiasis: no therapeutic advantage.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Approval; Europe; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles | 2008 |
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole | 2009 |
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis.
Topics: Amphotericin B; Antifungal Agents; Cholangitis, Sclerosing; Diagnosis, Differential; Exophiala; Female; Humans; Lymph Nodes; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2009 |
Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Multiple, Fungal; Genetic Variation; Genome, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Sequence Analysis, DNA; Thailand; Triazoles; Trichosporon; Voriconazole | 2010 |
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?
Topics: Administration, Oral; Antifungal Agents; Area Under Curve; Drug Administration Schedule; Food-Drug Interactions; Gastric Mucosa; Humans; Mycoses; Triazoles | 2009 |
Fusarium endophthalmitis following refractive lens exchange for correction of high myopia.
Topics: Anterior Chamber; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Mycoses; Myopia, Degenerative; Pyrimidines; Reoperation; Triazoles; Visual Acuity; Voriconazole | 2009 |
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Practice patterns in the management of fungal corneal ulcers.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Corneal Ulcer; Debridement; Drug Costs; Drug Therapy, Combination; Humans; Mycoses; Natamycin; Ophthalmology; Patients; Practice Patterns, Physicians'; Pyrimidines; Surveys and Questionnaires; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Cystic Fibrosis; Echinocandins; Fatal Outcome; Humans; Lung; Lung Diseases, Fungal; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Mycoses; Radiography, Thoracic; Retrospective Studies; Triazoles; Trichosporon | 2009 |
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2009 |
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
Keratitis resulting from Thielavia subthermophila Mouchacca.
Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole | 2009 |
Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults.
Topics: Adult; Antifungal Agents; Diarrhea; Drug Monitoring; Female; Humans; Male; Middle Aged; Mucositis; Mycoses; Retrospective Studies; Triazoles | 2009 |
Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
Topics: Amphotericin B; Antifungal Agents; Cities; Drug Resistance, Fungal; Fungi; Humans; Mexico; Microbial Sensitivity Tests; Mycoses; Triazoles; Urban Population | 2009 |
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.
Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.
Topics: Antifungal Agents; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fungi; Histone Deacetylase Inhibitors; Humans; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Triazoles | 2009 |
Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT.
Topics: Antifungal Agents; Cost-Benefit Analysis; Fluconazole; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Multivariate Analysis; Mycoses; Sensitivity and Specificity; Treatment Outcome; Triazoles | 2010 |
Voriconazole concentrations and outcome of invasive fungal infections.
Topics: Adult; Aged; Antifungal Agents; Australia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Algorithms; Antifungal Agents; Chromatography, High Pressure Liquid; Cohort Studies; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Models, Statistical; Mycoses; Population; Stem Cell Transplantation; Triazoles; Young Adult | 2010 |
[Prophylaxis use of posaconazole (P) in an hemato-oncology unit: a retrospective study].
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Therapy, Combination; Esomeprazole; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Service, Hospital; Postoperative Complications; Premedication; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Triazoles | 2010 |
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
Topics: Adolescent; Aged; Antifungal Agents; Chemoprevention; Drug Monitoring; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Serum; Triazoles; Voriconazole | 2011 |
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Chemical Analysis; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Transplantation; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult | 2010 |
How many steps along the path is too far?
Topics: Antifungal Agents; Child; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole pharmacokinetics and pharmacodynamics in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Linear Models; Male; Models, Biological; Mycoses; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Statistics, Nonparametric; Triazoles; Voriconazole; Young Adult | 2010 |
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole | 2009 |
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2010 |
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
Topics: Animals; Antifungal Agents; Ascomycota; Brain; Disease Models, Animal; Kidney; Liver; Lung; Male; Mice; Mycoses; Triazoles | 2010 |
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.
Topics: Adult; Antifungal Agents; Beauveria; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Mycoses; Pest Control; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole | 2010 |
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
Topics: Animals; Antifungal Agents; Chemoprevention; Disease Models, Animal; Drug Resistance, Fungal; Fusarium; Humans; Kidney; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Neutropenia; Treatment Outcome; Triazoles | 2010 |
Impact of mold infections in explanted lungs on outcomes of lung transplantation.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antifungal Agents; Female; Heart-Lung Transplantation; Humans; Incidence; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Survival Rate; Survivors; Triazoles; Voriconazole | 2010 |
The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
Topics: Administration, Topical; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2010 |
Efficacy of voriconazole in a murine model of invasive paecilomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Citrus paradisi; Colony Count, Microbial; Diet; Immunocompromised Host; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Drug costs and utilization after implementation of a posaconazole prophylaxis protocol in adults with acute myelogenous leukemia.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Drug Costs; Drug Utilization; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pharmacy Service, Hospital; Retrospective Studies; Triazoles | 2010 |
Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2010 |
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2010 |
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
Topics: Adult; Age Factors; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Saliva; Triazoles; Voriconazole | 2010 |
[Near-drowning and cerebral infections caused by fungi belonging to the Pseudallescheria / Scedosporium-complex].
Topics: Adolescent; Adult; Antifungal Agents; Brain; Central Nervous System Infections; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Mycoses; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Young Adult | 2010 |
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Fungistatic agents for treatment of dermatophytosis.
Topics: Antifungal Agents; Dermatomycoses; Humans; Mycoses; Tinea; Triazoles | 1946 |
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Alternaria and paecilomyces keratitis associated with soft contact lens wear.
Topics: Adult; Alternaria; Antifungal Agents; Contact Lens Solutions; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2010 |
Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia.
Topics: Adult; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillus; Bilirubin; Candida; Chemical and Drug Induced Liver Injury; Chemoprevention; Female; Humans; Liver Function Tests; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Triazoles; Young Adult | 2011 |
Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).
Topics: Animals; Antifungal Agents; Chordata; Chrysosporium; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reptiles; Triazoles; Voriconazole | 2010 |
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole | 2010 |
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Germany; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Polyenes; Retrospective Studies; Treatment Outcome; Triazoles; Young Adult | 2010 |
Cost-effectiveness of posaconazole compared with standard azole therapy for prevention of invasive fungal infections in patients at high risk in Switzerland.
Topics: Cost-Benefit Analysis; Decision Support Techniques; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Markov Chains; Models, Theoretical; Mycoses; Myelodysplastic Syndromes; Neutropenia; Risk; Switzerland; Treatment Outcome; Triazoles | 2010 |
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole | 2010 |
Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2010 |
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
Topics: Antifungal Agents; Cord Blood Stem Cell Transplantation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2011 |
Fusarium sepsis, voriconazole, and the skin.
Topics: Antifungal Agents; Fusarium; Humans; Mycoses; Pyrimidines; Sepsis; Skin; Triazoles; Voriconazole | 2010 |
Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Exophiala; Injections, Intraperitoneal; Itraconazole; Male; Mice; Mycoses; Treatment Outcome; Triazoles | 2010 |
Posaconazole salvage treatment in paediatric patients: a multicentre survey.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Humans; Male; Mycoses; Salvage Therapy; Time Factors; Treatment Outcome; Triazoles | 2010 |
Identification of Paecilomyces variotii in clinical samples and settings.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2010 |
Design, synthesis and antifungal activity of the novel water-soluble prodrug of antifungal triazole CS-758.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Humans; Mice; Microsomes, Liver; Mycoses; Prodrugs; Rats; Solubility; Triazoles | 2010 |
Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Fatal Outcome; Female; Heart Transplantation; Humans; Lung Transplantation; Middle Aged; Mycoses; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2010 |
Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based method.
Topics: Adult; Aged; Antifungal Agents; Chromatography, High Pressure Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles | 2010 |
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole | 2010 |
[Rhodotorula glutinis sepsis. A case report].
Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole | 2010 |
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.
Topics: Amphotericin B; Antifungal Agents; Azoles; Fungi; Humans; Japan; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Reference Standards; Triazoles; Yeasts | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.
Topics: Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Disease-Free Survival; Female; Humans; Itraconazole; Male; Middle Aged; Mycoses; Triazoles | 2011 |
Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Magnetic Resonance Spectroscopy; Mycoses; Spectrophotometry, Infrared; Sulfanilamide; Sulfanilamides; Triazoles | 2010 |
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
Topics: Amphotericin B; Animals; Antifungal Agents; Anura; Chytridiomycota; Clinical Protocols; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fungal spinal cord compression in metastatic synovial sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Lung Neoplasms; Mycoses; Neoplasm Recurrence, Local; Neoplasm Staging; Osteomyelitis; Pneumonectomy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Spinal Cord Compression; Spinal Cord Neoplasms; Triazoles; Voriconazole | 2011 |
Fusarium keratitis 3 weeks after healed corneal cross-linking.
Topics: Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoconus; Mycoses; Photosensitizing Agents; Pyrimidines; Riboflavin; Surgical Wound Infection; Tobramycin; Triazoles; Ultraviolet Rays; Voriconazole; Wound Healing; Young Adult | 2010 |
Oral voriconazole dose in children: one size does not fit all.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2010 |
Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
Topics: Adult; Antifungal Agents; Biopsy; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Male; Mycoses; Necrosis; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2010 |
Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles; Yeasts | 2010 |
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2011 |
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult | 2011 |
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles | 2011 |
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
Topics: Aged; Antifungal Agents; Female; Humans; Liver; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Severe Arthrographis kalrae keratomycosis in an immunocompetent patient.
Topics: Adult; Antifungal Agents; Candida albicans; Contact Lenses, Hydrophilic; Corneal Perforation; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Mitosporic Fungi; Mycoses; Pyrimidines; Reoperation; Triazoles; Voriconazole | 2011 |
Studies of the fungistatic and irritative qualities of agents suggested for the treatment of dermatophytosis.
Topics: Antifungal Agents; Dermatomycoses; Humans; Mycoses; Tinea; Triazoles | 1945 |
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis.
Topics: Administration, Topical; Aged; Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microscopy, Confocal; Mycoses; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole | 2011 |
A case of bovine valve endocarditis caused by Engyodontium album.
Topics: Adult; Antifungal Agents; Arthritis, Juvenile; Ascomycota; Beauveria; DNA, Fungal; Endocarditis; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Sequence Analysis, DNA; Triazoles; Voriconazole | 2011 |
Retrospective survey on the off-label use of posaconazole in pediatric hematology patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Hematologic Diseases; Humans; Mycoses; Off-Label Use; Retrospective Studies; Treatment Outcome; Triazoles | 2011 |
Posaconazole prophylaxis in patients with acute myelogenous leukaemia--results from an observational study.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia; Retrospective Studies; Triazoles | 2011 |
Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Graft vs Host Disease; Hematology; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Retrospective Studies; Stem Cell Transplantation; Triazoles; Young Adult | 2011 |
Posaconazole: clinical pharmacokinetics and drug interactions.
Topics: Antifungal Agents; Biological Availability; Drug Interactions; Fungi; Humans; Mycoses; Tissue Distribution; Triazoles | 2011 |
Posaconazole as part of the antifungal armamentarium in the intensive care unit--case reports from a surgical ICU.
Topics: Aged; Antifungal Agents; Female; Humans; Intensive Care Units; Male; Middle Aged; Mycoses; Postoperative Complications; Triazoles | 2011 |
Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Mycoses; Plasma; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimi
Topics: Antifungal Agents; Aspergillus fumigatus; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2011 |
Managing invasive fungal disease in immunocompromised patients.
Topics: Antibiotic Prophylaxis; Antibodies, Monoclonal; Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunotherapy; Infectious Disease Medicine; Mycoses; Risk Factors; Salvage Therapy; Travel; Triazoles | 2010 |
Resolution of recurrent fusarium arthritis after prolonged antifungal therapy.
Topics: Ankle Joint; Antifungal Agents; Arthritis, Infectious; Drug Therapy, Combination; Fusarium; Humans; Immunocompromised Host; Mycoses; Pyrimidines; Recurrence; Toe Joint; Triazoles; Voriconazole | 2011 |
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
Topics: Acute Disease; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Cost-Benefit Analysis; Decision Trees; Female; France; Fungi; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; National Health Programs; Triazoles | 2011 |
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Survival Analysis; Triazoles; Voriconazole; Young Adult | 2010 |
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2011 |
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole | 2011 |
A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Triazoles | 2011 |
Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.
Topics: Abscess; Adolescent; Adult; Antifungal Agents; Azoles; Caspofungin; Chemoprevention; DNA, Fungal; DNA, Ribosomal Spacer; Echinocandins; Eurotiales; Fatal Outcome; Female; Granulomatous Disease, Chronic; Histocytochemistry; Humans; Interferon-gamma; Lipopeptides; Male; Microscopy; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles | 2011 |
Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis.
Topics: Adult; Chemoprevention; Female; Fusarium; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Triazoles | 2011 |
Lack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections.
Topics: Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Mycoses; Treatment Outcome; Triazoles | 2011 |
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.
Topics: Antifungal Agents; Humans; Leukemia; Mycoses; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole | 2011 |
Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.
Topics: Antifungal Agents; Ascomycota; Brain Abscess; Cerebral Phaeohyphomycosis; Heart Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2011 |
A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; International Normalized Ratio; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Liver Cirrhosis; Mycoses; Nystatin; Paecilomyces; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole | 2011 |
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intraocular; Male; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Diagnosis and treatment of fungal infection after liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2011 |
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Chemoprevention; Drug Monitoring; Eating; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Triazoles; Young Adult | 2012 |
Optimising absorption of posaconazole.
Topics: Absorption; Administration, Oral; Adult; Aged; Antifungal Agents; Female; Humans; Male; Middle Aged; Mycoses; Serum; Triazoles | 2011 |
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole | 2011 |
Fatal disseminated infection due to Scedosporium prolificans in a patient with acute myeloid leukemia and posaconazole prophylaxis.
Topics: Acute Disease; Aged; Antifungal Agents; Fatal Outcome; Humans; Leukemia, Myeloid; Male; Mycoses; Scedosporium; Triazoles | 2011 |
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2011 |
The effect of enteral nutrition supplements on serum voriconazole levels.
Topics: Adolescent; Antifungal Agents; Enteral Nutrition; Food-Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Suspensions; Triazoles; Voriconazole | 2012 |
Synthesis and biological activity of novel 1-substituted phenyl-4-[N-[(2'-morpholinothoxy)phenyl]aminomethyl]-1H-1,2,3-triazoles.
Topics: Antifungal Agents; Drug Design; Fungi; Humans; Mycoses; Structure-Activity Relationship; Triazoles | 2011 |
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunologic Deficiency Syndromes; Infant; Injections, Intravenous; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2011 |
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult | 2011 |
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole | 2011 |
Dosing voriconazole in an obese patient.
Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycoses; Obesity; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Synthesis and electrophilic substitutions of novel pyrazolo[1,5-c]-1,2,4-triazolo[4,3-a]pyrimidines.
Topics: Acetic Acid; Antifungal Agents; Chemistry, Pharmaceutical; Fungi; Halogens; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mycoses; Pyrazoles; Pyrimidines; Triazoles | 2011 |
Synthesis and biological evaluation of dihydroindeno and indeno [1,2-e] [1,2,4]triazolo [3,4-b] [1,3,4]thiadiazines as antimicrobial agents.
Topics: Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Indans; Microbial Sensitivity Tests; Mycoses; Thiadiazines; Triazoles | 2011 |
Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.
Topics: Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Membrane; Chemoprevention; Epithelial Cells; Humans; Itraconazole; Lung; Macrophages; Mycoses; Triazoles | 2011 |
Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite.
Topics: Animals; Antifungal Agents; Bites and Stings; Diagnosis, Differential; Dogs; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Reflex Sympathetic Dystrophy; Tenosynovitis; Triazoles; Voriconazole | 2011 |
Post-traumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male patient due to surgical intervention and voriconazole therapy.
Topics: Adolescent; Antifungal Agents; Bone Transplantation; Fractures, Open; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Tibial Fractures; Transplantation, Autologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; Female; HIV; HIV Infections; Humans; Mycoses; Penicillium; Pyrimidines; Triazoles; Ulcer; Voriconazole; Vulvar Diseases; Young Adult | 2011 |
Synthesis, spectral characterization and biological activity of zinc(II) complexes with 3-substituted phenyl-4-amino-5-hydrazino-1, 2, 4-triazole Schiff bases.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coordination Complexes; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Schiff Bases; Triazoles; Zinc | 2012 |
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole; Young Adult | 2012 |
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Hospitalization; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Survival Analysis; Treatment Outcome; Triazoles; Young Adult | 2012 |
Synthesis and antimicrobial activity of pyrrolyl/pyrazolyl arylaminosulfonylmethyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Oxazoles; Thiadiazoles; Triazoles | 2011 |
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Posaconazole serum level on day 2 predicts steady state posaconazole serum level.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mycoses; Triazoles; Young Adult | 2012 |
Administration of voriconazole in patients with renal dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Cohort Studies; Humans; Leukemia, Myeloid, Acute; Middle Aged; Models, Biological; Mycoses; Myelodysplastic Syndromes; Suspensions; Triazoles; Young Adult | 2012 |
New heterocyclic compounds from 1,2,4-triazole and 1,3,4-thiadiazole class bearing diphenylsulfone moieties. Synthesis, characterization and antimicrobial activity evaluation.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Thiadiazoles; Triazoles | 2012 |
Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.
Topics: Aged, 80 and over; Antifungal Agents; DNA, Fungal; Female; Humans; Hypocreales; Lung Diseases, Fungal; Microscopy; Molecular Sequence Data; Mycoses; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole | 2012 |
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2011 |
Posaconazole is not superior to itraconazole for fungal prophylaxis in allogeneic blood and marrow transplantation.
Topics: Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Itraconazole; Male; Mycoses; Triazoles | 2012 |
Scedosporium apiospermum keratomycosis in a dog.
Topics: Animals; Antifungal Agents; Ascomycota; Dog Diseases; Dogs; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole | 2012 |
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2012 |
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.
Topics: Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Prospective Studies; Spain; Triazoles | 2012 |
Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies.
Topics: Adult; Antifungal Agents; Aspergillosis; Chemoprevention; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Risk Factors; Triazoles; Young Adult | 2012 |
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole | 2012 |
Paecilomyces lilacinus endophthalmitis following cataract surgery: a therapeutic challenge.
Topics: Aged; Antifungal Agents; Cataract Extraction; Endophthalmitis; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole-induced phototoxicity in children.
Topics: Chemoprevention; Child; Child, Preschool; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Risk Assessment; Triazoles; Voriconazole | 2012 |
Synthesis and biological evaluation of triazole derivatives as potential antifungal agent.
Topics: Antifungal Agents; Catalytic Domain; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycoses; Piperidines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2012 |
In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Drug Synergism; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2012 |
Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole | 2012 |
Posaconazole treatment in hematology patients: a pilot study of therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Drug Monitoring; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Middle Aged; Mycoses; Pilot Projects; Retrospective Studies; Treatment Outcome; Triazoles | 2012 |
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Sirolimus; Transplantation, Homologous; Triazoles | 2012 |
Simultaneous determination of triazole antifungal drugs in human plasma by sweeping-micellar electrokinetic chromatography.
Topics: Antifungal Agents; Chromatography, Micellar Electrokinetic Capillary; Humans; Mycoses; Triazoles | 2012 |
Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.
Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Plasma; Pyrimidines; Triazoles; Voriconazole | 2012 |
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Cohort Studies; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Retrospective Studies; Secondary Prevention; Transplantation, Homologous; Triazoles; Young Adult | 2013 |
Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.
Topics: Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Fungi; Humans; Immunocompromised Host; Incidence; Mycoses; Retrospective Studies; Triazoles | 2012 |
Fungal malignant otitis externa: pitfalls, diagnosis, and treatment.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Female; Humans; Male; Mycoses; Otitis Externa; Pseudomonas aeruginosa; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Nucleic Acid Synthesis Inhibitors; Phenytoin; Pyrimidines; Retrospective Studies; Rifampin; Treatment Outcome; Triazoles; Voltage-Gated Sodium Channel Blockers; Voriconazole | 2012 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Echinocandins; Female; Humans; Lipopeptides; Lung Transplantation; Male; Micafungin; Middle Aged; Mycoses; Risk; Time Factors; Triazoles | 2012 |
The management of febrile neutropenia in the posaconazole era: a new challenge?
Topics: Antifungal Agents; Antineoplastic Agents; Fever; Fungi; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mannans; Mycoses; Neutropenia; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles | 2012 |
Poor absorption of high-dose posaconazole in pediatric bone marrow transplant patients.
Topics: Absorption; Antifungal Agents; Bone Marrow Transplantation; Child; Humans; Infant; Male; Mycoses; Triazoles | 2012 |
Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Drug Design; Fluoroquinolones; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycoses; Staphylococcal Infections; Triazoles | 2012 |
Sinus fungal balls: characteristics and management in patients with host factors for invasive infection.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Endoscopy; Female; Humans; Male; Middle Aged; Mycoses; Osteolysis; Paranasal Sinus Diseases; Retrospective Studies; Risk Factors; Triazoles | 2012 |
Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Female; Fungi; Humans; Logistic Models; Male; Metoclopramide; Middle Aged; Mycoses; Phenytoin; Ranitidine; Retrospective Studies; Rifampin; Triazoles | 2012 |
Management of recurrent Paecilomyces lilacinus keratitis.
Topics: Aged; Humans; Keratitis; Male; Mycoses; Paecilomyces; Pyrimidines; Recurrence; Triazoles; Voriconazole | 2013 |
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole | 2012 |
Metal based new triazoles: their synthesis, characterization and antibacterial/antifungal activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Artemia; Bacteria; Bacterial Infections; Fungi; Humans; Mycoses; Spectrum Analysis; Toxicity Tests; Triazoles; Vanadates | 2012 |
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Lymphoproliferative Disorders; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles; Young Adult | 2012 |
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2012 |
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associaz
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy-Induced Febrile Neutropenia; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Febrile Neutropenia; Fungi; Hematologic Neoplasms; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Triazoles | 2013 |
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis.
Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Drug Interactions; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Plasma; Proton Pump Inhibitors; Stress, Physiological; Triazoles; Ulcer | 2012 |
Successful treatment of a severe case of fusariomycosis in a beluga whale (Delphinapterus leucas leucas).
Topics: Animals; Animals, Zoo; Antifungal Agents; Drug Administration Schedule; Extremities; Fusarium; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole; Whales | 2012 |
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation.
Topics: Antifungal Agents; Chemoprevention; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome; Triazoles | 2012 |
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
Topics: Animals; Antifungal Agents; China; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Penicillium; Pyrimidines; Rats; Terbinafine; Triazoles; Voriconazole | 2013 |
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Real-world experience with posaconazole prophylaxis in high-risk hematological patients in Singapore: a prospective audit.
Topics: Administration, Oral; Adult; Antifungal Agents; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Medical Audit; Middle Aged; Mycoses; Prospective Studies; Singapore; Treatment Outcome; Triazoles | 2013 |
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole | 2013 |
Adapting a global cost-effectiveness model to local country requirements: posaconazole case study.
Topics: Antifungal Agents; Cost-Benefit Analysis; Developed Countries; Drug Therapy, Combination; Fluconazole; Fungi; Humans; Itraconazole; Models, Economic; Mycoses; Triazoles | 2013 |
Antifungal prophylaxis in the haematological patient: a practical approach.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Biological Availability; Decision Trees; Drug Interactions; Echinocandins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Diseases; Mycoses; Myelodysplastic Syndromes; Postoperative Complications; Practice Guidelines as Topic; Premedication; Triazoles | 2012 |
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole | 2013 |
Evaluation of intravenous voriconazole in patients with compromised renal function.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole; Young Adult | 2013 |
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole | 2013 |
Synthesis, experimental, theoretical characterization and biological activities of 4-ethyl-5-(2-hydroxyphenyl)-2H-1,2,4-triazole-3(4H)-thione.
Topics: Anti-Infective Agents; Antioxidants; Bacteria; Bacterial Infections; Crystallography, X-Ray; Fungi; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Mycoses; Spectroscopy, Fourier Transform Infrared; Thiones; Triazoles | 2013 |
Reflections on the approach to treatment of a mycologic disaster.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole | 2013 |
Schizophyllum commune: a new organism in eye infection.
Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Keratitis; Male; Molecular Sequence Data; Mycoses; Polymerase Chain Reaction; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Voriconazole.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2002 |
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2002 |
New drugs, old drugs - dear drugs, cheap drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole | 2002 |
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
Topics: Antifungal Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2003 |
Paecilomyces variotii central nervous system infection in a patient with cancer.
Topics: Antifungal Agents; Breast Neoplasms; Central Nervous System Infections; Cerebrospinal Fluid; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Triazoles | 2003 |
Successful treatment of disseminated fusariosis.
Topics: Amphotericin B; Child, Preschool; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2003 |
Comment: caspofungin acetate for treatment of invasive fungal infections.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Improving the mouse model for studying the efficacy of voriconazole.
Topics: Animals; Beverages; Citrus paradisi; Disease Models, Animal; Fusarium; Kidney; Mice; Mice, Inbred ICR; Mycoses; Pyrimidines; Spleen; Triazoles; Voriconazole | 2003 |
Voriconazole in the treatment of invasive mold infections in transplant recipients.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2003 |
Posaconazole: SCH 56592.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Cytochrome P-450 Enzyme Inhibitors; Humans; Mycoses; Opportunistic Infections; Oxidoreductases; Sterol 14-Demethylase; Treatment Outcome; Triazoles | 2003 |
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 2003 |
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antifungal Agents; Brain; Brain Chemistry; Child; Child, Preschool; Drug Administration Schedule; Female; Guinea Pigs; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2003 |
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
[Update on voriconazole].
Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2003 |
[Finger nail polish with fungistatic effects].
Topics: Cosmetics; Humans; Mycoses; Nails; Triazoles | 1955 |
[Value in the Army of a fungistatic antibiotic active by buccal route: griseofulvin].
Topics: Anti-Bacterial Agents; Griseofulvin; Military Medicine; Military Personnel; Mycoses; Triazoles | 1961 |
Some investigative problems of the new oral fungistatic agent, griseofulvin.
Topics: Griseofulvin; Mycoses; Triazoles | 1959 |
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2003 |
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole | 2003 |
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole | 2003 |
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Triazoles | 2004 |
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2004 |
[Fungicidal and fungistatic effect of p-chlorophenoxethol and propylene phenoxethol on African dermatophytes].
Topics: Alkenes; Arthrodermataceae; Ethylene Glycols; Fungi; Humans; Mycoses; Triazoles | 1950 |
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis | 2004 |
Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Fusarium; Humans; Immunocompromised Host; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles | 2004 |
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
Topics: Antifungal Agents; Cornea; Databases, Factual; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Fungi; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Exophiala; Immunocompromised Host; Mice; Mice, Inbred BALB C; Mice, Nude; Mycoses; Survival Analysis; Triazoles | 2004 |
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
Topics: Antifungal Agents; Culture Media; Fatty Acids; Humans; Malassezia; Microbial Sensitivity Tests; Mycoses; Triazoles | 2004 |
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.
Topics: Adult; Anemia, Aplastic; Antifungal Agents; Female; Fusarium; Humans; Mycoses; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2004 |
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole | 2004 |
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole | 2004 |
Effect of voriconazole on a corneal abscess caused by fusarium.
Topics: Abscess; Antifungal Agents; Corneal Diseases; Eye Infections, Fungal; Fusarium; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Voriconazole-induced musical hallucinations.
Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2004 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Triazoles | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Caspofungin versus liposomal amphotericin B for empirical therapy.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole | 2005 |
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2004 |
Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fungi; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Triazoles | 2004 |
Synthesis and in vitro and in vivo structure-activity relationships of novel antifungal triazoles for dermatology.
Topics: Animals; Antifungal Agents; Dermatologic Agents; Guinea Pigs; Imidazoles; Itraconazole; Mice; Mitosporic Fungi; Mycoses; Naphthalenes; Stereoisomerism; Structure-Activity Relationship; Terbinafine; Triazoles | 2005 |
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
Topics: Adult; Antifungal Agents; Fusarium; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2005 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole | 2005 |
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].
Topics: Adult; Amsacrine; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diet; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Subcutaneous phaeohyphomycosis due to Exophiala spinifera in a renal transplant recipient].
Topics: Antifungal Agents; Cyclosporine; Exophiala; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leg; Middle Aged; Mycoses; Prednisone; Pyrimidines; Triazoles; Voriconazole | 2005 |
[Disseminated fusarium infection in two neutropenic children].
Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2005 |
Voriconazole in the treatment of invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Critical Care; Drug Interactions; Drug Monitoring; Humans; Immunocompromised Host; Infusions, Intravenous; Mycoses; Patient Selection; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2005 |
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Species Specificity; Thiazoles; Triazoles; Voriconazole | 2005 |
Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fungi; Geotrichum; Humans; Inpatients; Italy; Microbial Sensitivity Tests; Mycoses; Outpatients; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole | 2005 |
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts | 2005 |
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole | 2005 |
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2005 |
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts | 2005 |
Advances in antifungal therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Endogenous Phialemonium curvatum endophthalmitis.
Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole | 2005 |
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole | 2005 |
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2005 |
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
Topics: Animals; Antifungal Agents; Drug Synergism; Fungi; Lovastatin; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Cyclomyces tabacinus as a cause of deep tissue infection: the first case report.
Topics: Aged; Antifungal Agents; Arthritis, Infectious; Basidiomycota; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Topics: Antifungal Agents; Female; Fusarium; Humans; Immunocompromised Host; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
Topics: Aged; Antifungal Agents; Cellulitis; Comorbidity; Debridement; Disease Progression; Hepatitis C, Chronic; Humans; Immunocompromised Host; Leg Ulcer; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
Topics: Adult; Amphotericin B; Antifungal Agents; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Creatinine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leukemia; Lipids; Male; Middle Aged; Mycoses; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Pyrimidines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Black fluid from a traumatic wound.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Meropenem; Mycoses; Pyrimidines; Soft Tissue Infections; Thienamycins; Triazoles; Voriconazole; Wound Infection | 2006 |
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis | 2006 |
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Guinea Pigs; Humans; Kidney; Liver; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2006 |
Fusarium oxysporum pneumonia in an immunocompetent host.
Topics: Aged; Antifungal Agents; Bronchoscopy; Female; Fusarium; Humans; Immunocompetence; Mycoses; Pneumonia; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2006 |
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2006 |
[Clinical cases in medical mycology. Case no. 21].
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole | 2006 |
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2006 |
Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis.
Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Fasciitis, Necrotizing; Female; Humans; Mucormycosis; Mycoses; Triazoles; Trichosporon | 2006 |
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole | 2006 |
HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases.
Topics: Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Diseases; Humans; Mycoses; Triazoles | 2006 |
Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.
Topics: Adult; Antifungal Agents; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Esophagitis; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous; Triazoles | 2006 |
Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.
Topics: Child, Preschool; Humans; Knee Injuries; Male; Mitosporic Fungi; Mycoses; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole | 2006 |
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2006 |
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole | 2006 |
[Keratomycosis due to Cylindrocarpon lichenicola].
Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2006 |
Chronic refractory phaeohyphomycosis: successful treatment with posaconazole.
Topics: Adolescent; Adult; Alternaria; Amphotericin B; Antifungal Agents; Chronic Disease; Deoxycholic Acid; Drug Combinations; Female; Humans; Mouth Diseases; Mycoses; Treatment Outcome; Triazoles | 2006 |
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole | 2006 |
Voriconazole prophylaxis in lung transplant recipients.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole | 2006 |
Treatment of cutaneous infection by Alternaria alternata with voriconazole in a liver transplant patient.
Topics: Alternaria; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Liver Transplantation; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Skin; Triazoles; Voriconazole | 2006 |
Posaconazole (Noxafil) for invasive fungal infections.
Topics: Antifungal Agents; Candidiasis, Oral; Drug Interactions; Humans; Mycoses; Triazoles | 2006 |
Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.
Topics: Antifungal Agents; Biopsy, Fine-Needle; Blood Sedimentation; Child; DNA, Fungal; Genetic Diseases, X-Linked; Granulomatous Disease, Chronic; Humans; Male; Microscopy; Molecular Sequence Data; Mycoses; Osteomyelitis; Penicillium; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Triazoles; Voriconazole | 2006 |
Topical and oral voriconazole in the treatment of fungal keratitis.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Keratitis; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole | 2006 |
Voriconazole and fungal keratitis: a report of two treatment failures.
Topics: Administration, Topical; Aged, 80 and over; Antifungal Agents; Colletotrichum; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2006 |
Prophylaxis and aspergillosis--has the principle been proven?
Topics: Antifungal Agents; Aspergillosis; Fluconazole; Graft vs Host Disease; Humans; Itraconazole; Mycoses; Neutropenia; Opportunistic Infections; Triazoles | 2007 |
Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592).
Topics: Administration, Oral; Adult; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles | 2007 |
Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2007 |
Posaconazole.
Topics: Antifungal Agents; Aspergillosis; Europe; Humans; Mycoses; Triazoles | 2007 |
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Mycoses; Prospective Studies; Salvage Therapy; Transplantation, Homologous; Triazoles | 2007 |
Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antifungal Agents; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mycoses; Neutropenia; Triazoles | 2007 |
Management of tunnel fungal infection with voriconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Microsurgery; Mycoses; Pyrimidines; Surgical Wound Infection; Triazoles; Visual Acuity; Voriconazole | 2007 |
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Opportunistic Infections; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2007 |
Posaconazole prophylaxis in hematologic cancer.
Topics: Antifungal Agents; Bilirubin; Chemical and Drug Induced Liver Injury; Fluconazole; Graft vs Host Disease; Humans; Liver Diseases; Mycoses; Transaminases; Triazoles | 2007 |
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2007 |
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2007 |
Quantitative Fusarium spp. and Microdochium spp. PCR assays to evaluate seed treatments for the control of Fusarium seedling blight of wheat.
Topics: Antifungal Agents; Ascomycota; Benzimidazoles; Biphenyl Compounds; Crops, Agricultural; Dioxoles; DNA, Fungal; Fusarium; Mycoses; Plant Diseases; Polymerase Chain Reaction; Pyrroles; Seedlings; Seeds; Triazoles; Triticum | 2007 |
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2007 |
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.
Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole | 2007 |
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
The fusarium keratitis outbreak: not done yet?
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole | 2007 |
Third-time lung transplant using extended criteria lungs.
Topics: Adult; Antifungal Agents; Brain Death; Humans; Lung Transplantation; Male; Mycoses; Patient Selection; Postoperative Complications; Pyrimidines; Reoperation; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Posaconazole: a next-generation triazole antifungal.
Topics: Animals; Antifungal Agents; Aspergillus; Candida; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Models, Animal; Molecular Structure; Mycoses; Triazoles | 2007 |
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole | 2007 |
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2007 |
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole | 2007 |
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment].
Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Disease Models, Animal; Echinocandins; Exophiala; Female; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred ICR; Mycoses; Survival Analysis; Triazoles | 2007 |
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
Topics: Antifungal Agents; Brain Abscess; Combined Modality Therapy; Female; Fusarium; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro efficacy of voriconazole against clinical isolates of Scytalidium spp. from clinical lesions.
Topics: Antifungal Agents; Humans; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2007 |
Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Hypersensitivity; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Sinusitis; Triazoles; Voriconazole | 2007 |
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2008 |
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Female; Fusarium; Humans; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Spores, Fungal; Toll-Like Receptors; Triazoles; Virulence; Voriconazole | 2007 |
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues.
Topics: Adult; Alternaria; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection.
Topics: Adult; Biological Availability; Fusarium; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunocompromised Host; Interferon-gamma; Leukemia; Male; Mycoses; Neutropenia; Recombinant Proteins; Salvage Therapy; Treatment Outcome; Triazoles | 2008 |
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2008 |
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole | 2009 |
Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
Topics: Adult; Antifungal Agents; Blister; Bone Marrow Transplantation; Extremities; Female; Fusarium; Graft vs Host Disease; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2008 |
Recurrent Trichosporon asahii glossitis: a case report.
Topics: Administration, Inhalation; Adult; Antifungal Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Resistance, Fungal; Glossitis; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Recurrence; Triazoles; Trichosporon; Voriconazole | 2008 |
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2008 |
[Antifungal activity of posaconazole and caspofungin in yeast causing invasive fungal infection (2002-2003). E-test system evaluation].
Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Rhodotorula; Sensitivity and Specificity; Species Specificity; Triazoles | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
[Usefulness of voriconazole in treatment of Phoma glomerata after penetrating injury].
Topics: Aged; Antifungal Agents; Ascomycota; Eye Injuries, Penetrating; Humans; Male; Mycoses; Pyrimidines; Retinal Detachment; Triazoles; Voriconazole | 2008 |
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole | 2008 |
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole | 2008 |
Numbers needed to treat with posaconazole prophylaxis to prevent invasive fungal infection and death.
Topics: Antifungal Agents; Chemoprevention; Humans; Mycoses; Triazoles | 2008 |
Combined therapy in treatment of murine infection by Fusarium solani.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole | 2008 |
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Male; Mice; Microbial Sensitivity Tests; Mycoses; Triazoles; Trichosporon | 1995 |
Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Carriers; Drug Therapy, Combination; Evaluation Studies as Topic; Liposomes; Male; Mice; Mycoses; Triazoles; Trichosporon | 1994 |
In vitro and in vivo antifungal activities of D0870, a new triazole agent.
Topics: Animals; Antifungal Agents; Culture Media; Fungi; Hydrogen-Ion Concentration; Immunosuppression Therapy; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycoses; Stereoisomerism; Triazoles | 1993 |
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1997 |
In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole.
Topics: Antifungal Agents; Culture Media; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Morpholines; Mycoses; Triazoles | 1997 |
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts.
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts | 1998 |
[Antifungal drugs: the new frontier].
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole | 1998 |
Treatment of murine fusariosis with SCH 56592.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Fusarium; Kidney; Male; Mice; Mycoses; Triazoles | 1999 |
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
ER 30346. BMS 207147.
Topics: Animals; Antifungal Agents; Dogs; Drug Interactions; Drugs, Investigational; Fungi; Humans; Mycoses; Rats; Thiazoles; Triazoles | 1999 |
SCH 56592.
Topics: Animals; Antifungal Agents; Candidiasis; Chagas Disease; Drugs, Investigational; Fungi; Humans; Mice; Mycoses; Parasitic Diseases; Triazoles | 1999 |
Voriconazole. UK 109496.
Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1999 |
SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei").
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Central Nervous System Fungal Infections; Disease Models, Animal; Female; Itraconazole; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mycoses; Triazoles | 2000 |
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole | 2000 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
Optimal use of the newer antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drugs, Investigational; Humans; Immunocompromised Host; Mycoses; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles | 2000 |
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole | 2000 |
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2001 |
In vitro antifungal activity of posaconazole against various pathogenic fungi.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2001 |
In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.
Topics: Animals; Antifungal Agents; Aspergillus; Candida; Cryptococcus neoformans; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Mycoses; Treatment Outcome; Triazoles | 2002 |
Empirical antifungal therapy--new options, new tradeoffs.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole | 2002 |
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole | 2002 |
In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2002 |
Decisions about voriconazole versus liposomal amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2002 |
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
Topics: Adult; Aged; Amphotericin B; Animals; Antifungal Agents; Child, Preschool; Disease Models, Animal; Female; Fluconazole; Humans; Immunocompromised Host; Male; Mice; Miconazole; Middle Aged; Mycoses; Triazoles; Trichosporon | 1992 |
[Clinical features of 32 cases of fungal pneumonia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Cross Infection; Female; Fungi; Humans; Imidazoles; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Pneumonia; Radiography; Triazoles | 1991 |
New strategies developed to prevent serious infections in children.
Topics: Agranulocytosis; Amphotericin B; Cell Wall; Child, Preschool; Humans; Mycoses; Peptides; Triazoles | 1991 |
Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Culture Media; Disease Models, Animal; Female; Guinea Pigs; Histoplasmosis; Humans; Mice; Mycoses; Nephritis; Rats; Sporotrichosis; Tinea; Triazoles | 1990 |
Differential staining of fungi in clinical specimens using fluorescent whitening agent (Blankophor).
Topics: Fluorescent Dyes; Fungi; Humans; Microscopy, Fluorescence; Mucous Membrane; Mycoses; Skin; Staining and Labeling; Triazoles | 1987 |
Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Bone Marrow Transplantation; Drug Administration Schedule; Female; Fluconazole; Humans; Male; Melphalan; Middle Aged; Mycoses; Transplantation, Autologous; Triazoles; Whole-Body Irradiation | 1989 |
[A clinical evaluation of fluconazole in the treatment of deep mycosis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Fungi; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Triazoles | 1989 |
[Clinical evaluation of fluconazole in patients with mycotic infection].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidiasis, Oral; Drug Evaluation; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Sepsis; Tissue Distribution; Triazoles | 1989 |
[Experience of fluconazole in pediatric patients].
Topics: Administration, Oral; Adolescent; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Infant; Male; Mycoses; Risk Factors; Triazoles | 1989 |
[Clinical evaluation of fluconazole].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Ambulatory Care; Antifungal Agents; Antigens, Fungal; Candidiasis; Child; Cryptococcosis; Cryptococcus neoformans; Drug Evaluation; Esophagitis; Female; Fluconazole; Humans; Male; Meningitis; Middle Aged; Mycoses; Renal Dialysis; Triazoles | 1989 |
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles | 1989 |
[Fluconazole treatment of systemic mycoses].
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance; Endophthalmitis; Female; Fluconazole; Humans; Leukopenia; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Triazoles | 1989 |
[Recent antifungal agents].
Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines; Mycoses; Triazoles | 1989 |
[International symposium: Fluconazole in fungal infections. 20-21 January 1989, Berlin. Abstracts].
Topics: Antifungal Agents; Fluconazole; Humans; Mycoses; Triazoles | 1989 |
Ocular toxicity after intravitreal injection of terconazole.
Topics: Animals; Antifungal Agents; Electroretinography; Endophthalmitis; Eye; Mycoses; Ophthalmoscopy; Rabbits; Triazoles | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
Chemotherapy of the pulmonary mycoses. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987.
Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Lung Diseases; Mycoses; Triazoles | 1988 |
[Antimycotic agents in generalized fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles | 1988 |
Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents.
Topics: Aspergillus fumigatus; Candida; Candida albicans; Chromatography, High Pressure Liquid; Cryptococcus neoformans; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Ketoconazole; Mucorales; Mycoses; Rifampin; Triazoles | 1986 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles | 1987 |